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ABSTRACT 
Carbon-Based Nanostructures as Advanced Contrast Agents for Magnetic Resonance 
Imaging 
by 
Jeyarama S. Ananta Narayanan 
Superparamagnetic carbon-based nanostructures are presented as contrast agents 
(CAs) for advanced imaging applications such as cellular and molecular imaging using 
magnetic resonance imaging (MRI). Gadolinium-loaded, ultra-short single-walled carbon 
nanotubes (gadonanotubes; GNTs) are shown to have extremely high rl relaxivities 
(contrast enhancement efficacy), especially at low-magnetic field strengths. The inherent 
lipophilicity of GNTs provides them the ability to image cells at low magnetic field 
strength. 
A carboxylated dextran-coated GNT (GadoDex) has been synthesized and 
proposed as a new biocompatible high-performance MRI CA. The rl relaxivity is ca. 20 
times greater than for other paramagnetic Gd-based CAs. This enhanced relaxivity for 
GadoDex is due to the synergistic effects of an increased molecular tumbling time ('tR) 
and a faster proton exchange rate ('tm). 
GNTs also exhibit very large transverse relaxivities (r2) at high magnetic fields ~ 
3 T). The dependence of the transverse relaxation rates (especially R2 *) of labeled cells 
on GNT concentration offers the possibility to quantify cell population in vivo using R2 * 
mapping. The cell-labeling efficiency and high transverse relaxivities of GNTs has 
enabled the first non-iron oxide-based single-cell imaging using MRI. 
The residual metal catalyst particles of SWNT materials also have transverse 
relaxation properties. All of the SWNT materials exhibit superior transverse relaxation 
properties. However, purified SWNTs and US-tubes with less residual metal content 
exhibit better transverse relaxivities (r2), demonstrating the importance of the SWNT 
structure for enhanced MRI CA performance. 
A strategy to improve the rl relaxivity of Gd-CAs by geometrically confining 
them within porous silicon particles (SiMPs) has been investigated. The enhancement in 
relaxivity is attributed to the slow diffusion of water molecules through the pores and the 
increase in the molecular tumbling time of the nanoconstruct. The universality of the 
strategy has been demonstrated for GNTs, gadofullerols and clinically-used Magnevist®. 
In summary, primary nanoscale confinement of Gd3+ ions in US-tubes has 
resulted in a new class of CAs which could revitalize low-field contrast-enhanced MRI, 
while extending and complementing current high-field MRI technology, as well. The 
observed boost in relaxivity upon a secondary nanoscale confinement of Gd-CAs within 
SiMPs suggests that additional unforeseen nanoscale effects may have the potential to 
further boost performance of MRI CAs. 
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CHAPTER! 
INTRODUCTION 
Magnetic Resonance Imaging (MRl) 
The 2003 Nobel Prize for Physiology or Medicine was awarded to Paul Lauterbur 
and Peter Mansfield in recognition of their contribution to what is now called magnetic 
resonance imaging (MRl). The first MR images of human were published in the 1977,1 
and ever since, MRI has evolved into one of the most powerful, non-invasive imaging 
modalities used in diagnostic medicine? MRI is essentially an extension of nuclear 
magnetic resonance (NMR) spectroscopy, a widely-used characterization technique in the 
field of chemistry. The superior resolution, greater anatomical details, and excellent soft 
tissue contrast make MRl a preferred diagnostic imaging modality over other techniques 
such as computed tomography (CT) and ultrasound.3,4 In addition, the non-invasive 
nature ofMRl helps in procedures involving imaging over longer periods of time. 
Nuclear spin, an inherent property of water protons which are present in 
abundance in the human body, is manipulated by an external magnetic field to obtain 
magnetic resonance (MR) images. Each nuclear spin acts like a magnetic dipole, and in 
the absence of an external magnetic field, are oriented in random directions (Figure la). 
For a single spin system like IH, the application of an external field (Bo; along Z-axis) 
results in two different energy states: 1) a low-energy state corresponding to the 
alignment of nuclear spins parallel to the applied field and 2) a quantized high-energy 
state arising from anti-parallel alignment (Figure Ib). The population distribution of 
nuclear spins of these two energy states is determined by the Boltzmann distribution. 
Generally, a greater number of spins align parallel to the Bo field (low energy state), 
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resulting in a net magnetization vector (NMV). The NMV precesses around the applied 
magnetic field (Bo) at a particular frequency known as the Larmor frequency (Figure Ie) 
given by the expression ro = yBo (y is the gyromagnetic ratio specific for the NMR active 
isotope). When an external radiofrequency (RF) pulse (frequency = Larmor frequency) is 
applied in a direction perpendicular to the Z-axis, it excites the nuclear spin from the low-
energy ground state (along the longitudinal or Z-axis) to the higher-energy excited state 
(along the transverse or XY-axis) (Figure Id). Once the external pulse is removed after a 
short duration, the time taken for the excited state spin to return to its equilibrium 
position is termed the relaxation time. The relaxation process can occur via two 
mechanisms (Figure Ie): 1) relaxation along the axis of the applied magnetic field 
(longitudinal relaxation time; T 1) and 2) relaxation along the axis perpendicular to the 
applied magnetic field (transverse relaxation time; T 2).4, 5 
a) 
d) 
" 
" 
b) 
Bo field 
External ) L 
RF pulse 
Transverse XY axis 
e) 
e) 
T 2- relaxation 
Bo field 
1 T.- relaxation 
Figure 1. Schematic representation of proton relaxation mechanisms for MRI. 
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The intensity of the MR signal from a tissue is dependent on three important 
parameters, namely: 1) Tl-relaxation time of the tissue, 2) Trrelaxation time of the tissue 
and, 3) the proton density in the tissue. Different tissues have different relaxation times 
(both TI and Tz) and proton densities. However, these differences are very subtle and 
require a variety of mathematical sequences to preferentially differentiate between the 
three parameters. 
Role of Contrast Agents in MRl 
Growing advancements in MRI led to the development of contrast agents (CAs) 
to improve the sensitivity and diagnostic confidence.6, 7 In 2007, there were about 28 
million MRl procedures performed in US alone, and nearly 45% of them used CAs for 
improving the diagnostic confidence.8 CAs improve the sensitivity of MRl by decreasing 
the relaxation time of water protons in and around their vicinity. Most of the clinically-
used CAs are paramagnetic in nature and, therefore, have a permanent magnetic moment. 
The magnetic moment of the paramagnetic ions exhibit a dipole-dipole interaction with 
magnetic moments of water protons in their vicinity and molecular motions cause random 
fluctuations to these dipolar magnetic interactions resulting in reduced T I and T z 
relaxation times. The reduction in the relaxation times of water protons is utilized to 
improve image contrast in MRI.7, 9 
The high-spin paramagnetic Gd3+ ion is the most extensively used T I relaxation agent 
in MRl, since it has seven unpaired f-electrons (the maximum number of unpaired 
electrons observed for any atom or metal ion), a large magnetic moment (63 J.1BZ), and 
because of their symmetric ground sate (8S), the Gd3+ ions exhibit slow electronic 
4 
relaxation properties. Slow electronic relaxation produces strong oscillations near the 
Larmor frequency and has a pronounced effect on the T 1 relaxation process.6, 7 
Understanding the Relaxation Mechanism of Gd3+-complexes 
Aqueous Gd3+ ion is toxic and has to be sequestered for biological use. 
Traditional sequestering methods use a variety of linear and macrocyclic chelates (Figure 
2), and the relaxation properties of these Gd3+ -chelate compounds have been extensively 
studied and characterized. 1 0 As mentioned above, the paramagnetic relaxation of water 
protons originates from dipole-dipole interaction between water protons and the 
fluctuating magnetic field caused by unpaired electrons in CAs. This fluctuating magnetic 
field vanishes rapidly with distance. Hence, for paramagnetic CAs to be effective, a 
mechanism by which the paramagnetic effect is transferred efficiently to the water 
protons surrounding the CAs is essential.7 
t o-('" 
N, : ,N~O ( '1'3+)'" r 0 :' ·---Gd----:O ~ '" , , 
° N0 . N) 
HO,\\ 
o 
[Gd(DOTA)(H20)]1-
Dotarem ® 
Figure 2. Depiction of Gd-chelate MRI CAs in clinical use. 
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There are two mechanisms by which the paramagnetic effect can be transferred to 
the bulk. The first mechanism (inner-sphere mechanism) involves the bonding of water 
molecules in the first coordination sphere of the metal ion. These inner-sphere water 
molecules then exchange with bulk protons propagating the paramagnetic effect. Thus, 
the inner-sphere mechanism depends on the number of water molecules (q) in the first 
coordination sphere of the metal ion, the residence time of the protons in the inner sphere 
('tm) , and the molecular tumbling time ('tR) of the paramagnetic CA with its inner-sphere 
water molecule. The second mechanism (outer-sphere mechanism) involves the random 
translation diffusion of water protons in the surrounding of the paramagnetic center. For 
most Gd3+-chelate CAs, inner-sphere and outer-sphere mechanisms contribute equally 
(Figure 3).11 
L L 
L L L 
L L L 
L L L 
Inner-Sphere Secondary-Sphere Outer .. Sphere 
" ....--) Y 
50 % of relaxivity 50 % of relaxivity 
Figure 3. Schematic representation of contribution from inner- and outer-sphere relaxivity 
for Gd3+-chelate CAs. 
Considerable progress has been made in the synthesis and design of clinical Gd3+_ 
based CAs. In spite of all the progress, they still have several limitations. Chelation of the 
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Gd3+ ion with multi dentate ligands decrease the number of coordination sites (q) 
available for water proton exchange (8 sites for free Gd3+ ion compared to 1-2 sites for 
Gd3+ chelate compounds), resulting in reduced relaxivity. Also, almost all of the 
clinically-used CAs are extracellular fluid space (ECF) agents with very low blood 
retention times (ca. 60 s), and they distribute extracellularly and excrete via the kidneys. 
For applications such as magnetic resonance angiography (MRA), agents with a longer 
blood plasma half-life are required. In addition, for cellular and molecular imaging using 
MRI, a very high relaxivity (~100 mM-Is-I) CA is required to compensate for the nM 
restriction in cell-surface receptor site concentration. 12 Current clinical CAs suffer from 
very low relaxivities (rl ~ 4 mM-Is-I) and therefore cannot be used for such applications. 
Hence, there is an important need to develop new MRI CAs with superior efficacies and 
more desirable physiochemical properties. 
Carbon Nanostructure-based MRI Contrast Agents 
The discovery of fullerenes, an allotrope of carbon, by Smalley, Curl, and Kroto 
marked the beginning of the field of "Carbon Nanotechnology"Y The two main building 
blocks of Carbon Nanotechnology are: 1) fullerenes (C60, C7o, C74, C76 etc.), which are 
hollow and spherical or nearly-spherical molecules (Figure 4a) and 2) carbon nanotubes, 
which are hollow all-carbon cylindrical materials (Figure 4b). Single-walled carbon 
nanotubes (SWNTs) can be visualized as a single sheet of graphene rolled upon itself to 
assume the shape of a seamless cylinder. 14, 15 All the carbon atoms of these 
nanostructures are surface atoms, which produces a hollow, internal space within the 
nanostructures that can be potentially filled with medically-interesting atoms, ions, and 
even small molecules. 16, 17 When magnetically-active Gd3+ ions are encapsulated within 
7 
the interior of these highly-ordered nanostructures (Gadonanotubes; GNTs), a new class 
of MRI CA results. 
a) b) 
300 nm - >2 J.I 
0.70 nm 
c) d) 
0.70 nm -1nm 
Figure 4. Building blocks of Carbon-based MRI CAs: a) C60 fullerene, b) single-walled 
carbon nanotube (SWNT), c) Gadofullerene (GF), and d) Gadonanotube (GNT). 
Gadonanotubes as MRI Contrast Agents 
Nanoscale loading and confinement of Gd3+ ions inside ultra-short single-walled 
carbon nanotubes (US-tubes) resulted in a high-performance MRI CA, Gadonanotubes 
(GNTs; Figure 4d).18 The Gd3+ ions are present in the form of clusters located at the 
defect sites on the sidewalls of the US-tubes which are produced during the SWNT 
cutting process. The GNTs resemble linear superparamagnetic molecular magnets with 
IH relaxivities 40-90 times greater than any current Gd3+-based CA in clinical use. 
Because of the hydrophobic nature of the US-tubes, GNTs do not disperse well in water. 
However, a variety of biocompatible surfactants have been used to impart 
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biocompatibility to GNTs. The relaxivities (per Gd3+ ion) of the GNTs dispersed in 
different surfactants, along with the aqueous [Gd(H20)s]3+ ion, are presented in Table I 
at a clinically-relevant field strength of 1.41 T. The rl relaxivity of the GNT is about 20 
times greater than that of the [Gd(H20)s]3+ ion at 1.5 T. When compared to clinically-
used Gd3+-based CAs, GNTs are about 40 times more efficacious at 1.5 T. 
Table I. Longitudinal proton relaxivities of GNTs. Measurements were performed at 60 
MHz and 37°C. +: dispersed in sodium dodecyl benzene sulfonate (SDBS), +: 
dispersed in Pluronic. 
Advantages of Gadonanotube Contrast Agent 
GNTs as MRl CAs offer several unique advantages over current clinically-used Gd3+_ 
based CAs, such as: 
1) The Gd3+ ions are trapped within a biologically-stable carbon cage (carbon 
nanotubes), preventing the release of toxic, free Gd3+ ions. In contrast, some 
clinical CAs are susceptible to the release of Gd3+ ion, especially in patients with 
kidney disease, leading to nephrogenic systemic fibrosis (NSF).19 
2) The external all-carbon surface of GNTs can be chemically functionalized to 
control toxicity, enhance biocompatibility, and provide targeting ability using 
'b d' d/ t'd 20 21 antI 0 les an or pep I es. ' 
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3) The nanoscale confinement of Gd3+ ions inside the carbon nanotubes provides 
them with an unusual metal-ion environment, resulting in remarkably high 
relaxivities (rl >100 mM-Is- I per Gd3+ ion). In fact, the GNTs are the highest 
performing T I-weighted MRI CA known, making them especially desirable 
candidates for future applications in molecular imaging. 
4) The inherent lipophilicity of GNTs provides them the ability to efficiently 
translocate across cell membranes, without evidence of cytotoxicity. Once target 
cells are internally labeled with GNTs in sufficient concentration, high-resolution 
cellular imaging using MR! may well be achievable. 
This work details the development of GNTs as high-performance CAs for advanced 
imaging applications such as cellular and molecular imaging using MR!. 
CHAPTER 2 
Gadonanotubes as Low-field MRI Contrast Agents 
Introduction to Low-field Magnetic Resonance Imaging 
10 
Magnetic resonance imaging (MRI) scanners are generally classified into three types on 
the basis of the magnetic field strength: 1) low-field MRI scanners « 0.5 T), 2) mid-field 
MRI scanners (0.5-1.0 T), and 3) high-field MRI scanners (1.0 T and above). Most of the 
high-field instruments use expensive cryogenically-cooled superconducting magnets to 
generate the magnetic fields. The high cost associated with high-field instruments limits 
the use of MRI as an imaging modality for all diagnostic purposes.22, 23 The main 
motivation behind the development of low-field scanners is their cost-effectiveness. Low-
field systems also offer other advantages, such as an "open" design suitable for 
interventional MRI and less contraindications (associated with imaging patients with 
metallic implants). However, the main disadvantage with low-field systems is the low 
signal-to-noise ratio (SNR) resulting in lower resolution of images. In addition, most 
tissues exhibit lower relaxation times (T 1 and T 2) at low magnetic field strengths.24, 2S 
Even though there is no conclusive evidence of low-field MRI (and its low resolution) 
adversely affecting diagnostic outcome, high-field systems are more popular for 
diagnostic imaging.23 To circumvent the low resolution of low-field MRI systems, longer 
scan times have been proposed. However, longer scan times can result in greater image 
degradation due to patient movement. In addition, CAs have been used improve the 
SNR in low-field MR images (Figure 5). However, many of the clinically-used T1-
weighted MRI CAs (mainly Gd-based complexes) have very low efficiency and exhibit 
little or no field-dependency in their contrast enhancement properties, as exemplified by 
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the Magnevist® data on Figure 6. It has been observed that, to obtain a comparable 
resolution at lower magnetic fields, at least twice the amount of CA (compared to high-
field scans) must be administered to the patients?6, 27 Such high doses are not advisable, 
since clinically-used Gd-based CAs are alleged to cause nephrogenic systemic fibrosis 
(NSF) in some patients with renal dysfunction?8 We have reported that GNTs are high-
performance MRI CAs with relaxivity (contrast enhancement efficacy) -40 times greater 
than that of current clinical Gd-based agents at 1.5 T (Figure 6).18 Unlike other Gd-based 
agents, GNTs exhibit much higher relaxivities at lower magnetic field strengths (Figure 
6). The extremely high rl relaxivity (as high as 600 mM-1-s-1) should overcome the low 
resolution associated with low-field MRI. In addition, cellular and molecular imaging 
using MRI requires very high-relaxivity agents (r> 100 mMls-I) accompanying with 
cell-labeling efficiency.12 The lack of efficient intracellular labeling for current Gd-based 
CAs and their very low relaxivity (- 4 mM-1S-1) have alternatively resulted in the 
development of iron oxide (SPIO)-based CAs for cellular and molecular imaging.29,30 
However, SPIO-based CAs (T2-weighted CAs) belong to the negative CA category 
(darkening of the image) and create signal voids in its proximity. Such signal voids are 
hard to differentiate from hypo intense signals arising from other sources. This drawback 
has greatly limited the progress of MR molecular imaging. The lipophilic nature of GNTs 
provides them with the ability to trans locate through cell membranes without the aid of 
transfection agents or advanced labeling techniques. The efficient intracellular 
localization for GNTs, along with their very-high relaxivity at all field strengths, has 
produced the opportunity for a new paradigm in MR molecular imaging. In this chapter, 
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the ability of GNTs to function as powerful Tl-weigthed, low-field MRI CAs and their 
potential for cellular and molecular imaging at low fields is considered in detail. 
Figure 5. Contrast-enhanced Tl-weighted images of skull base meningioma at a) 1.5 T (slice 
thickness 4 mm) and b) 0.1 T (slice thickness 4 mm) using the same image 
acquisition settings. Both the images are equally diagnostic but image a shows 
higher resolution. Reproduced with permission from Ref 27. 
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Figure 6. Nuclear Magnetic Relaxation Dispersion (NMRD) profile for bundled GNTs 
(dispersed in SDBS). For comparison, NMRD profile of a clinically-used CA, 
(Magnevist®;[Gd-DTPA]2-), is also presented. The measurements were 
performed at 37°C. 
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MATERIALS AND METHODS 
Synthesis of GNTs 
GNTs were synthesized using our published protocol.18 Briefly, full-length 
single-walled carbon nanotubes produced by electric arc discharge process were cut into 
ultra-short tubes (US-tubes) of 20-80 nm in length by fluorination followed by pyrolysis 
at 1000 °C in an inert Ar atmosphere.31 As obtained US-tubes were sonicated with 
concentrated HCI to remove metal catalyst impurities. Due to their hydrophobic nature, 
US-tubes exist in the form of various-sized bundles. Part of the US-tubes was reduced 
using Nao ITHF to generate predominantly individual US-tubes. 16 Both the bundled US-
tubes and individual US-tubes were loaded with Gd3+ ions using a simple aqueous 
loading method. Briefly, 100 mg of US-tubes (bundled or individual) were added to 100 
mL of aqueous GdCl3 solution (1 mg/mL) and bath sonicated for 60 minutes. The 
solution was allowed to settle overnight. The gadolinium-loaded US-tubes 
(Gadonanotubes; GNTs) flocculated at the bottom. The supernatant was discarded and 
flocculated GNTs were washed repeatedly with DI water to remove any external Gd3+ 
ions adhering to the US-tube sidewalls. Figure 7 shows the schematic representation of 
an individual GNT. 
mdewnll defects 
~I 
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Figure 7. Schematic representation of an individual GNT. 
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For MRI phantom measurements, solutions of bundled GNTs and individual 
GNTs were prepared using 1.0 % solution of a biocompatible Pluronic® surfactant 
(polyethylene oxide-polypropylene oxide block copolymer). In addition, a solution of 
individual GNTs coated with carboxylated dextran (GadoDex) was also prepared. The 
synthesis and characterization of GadoDex is discussed in detail in Chapter 3. The Gd3+ 
content of each phantom was determined using inductively-coupled plasma optical 
emission spectrometry (ICP-OES, Perkin-Elmer Optima 3200V). GNT phantoms had 
final Gd3+-ion concentrations of (a) 104 f.1M for bundled GNTs (b) 83 11M for individual 
GNTs, and (c) 39 11M for GadoDex, respectively. For comparison, a solution of 
clinically-used Gd-based CA, Gd-DTPA (Magnevist®), at 20 mM Gd3+ was prepared in 
sterile physiological saline. All the samples were sealed in cylindrical containers of 1 cm 
diameter. 
In Vitro Phantom Imaging 
MRI experiments were performed using a 0.2 T open MRI system (Signa Profile, 
General Electric, Milwaukee, WI). The system was interfaced with a Tecmag Apollo 
console (Tecmag, Houston, TX). The GNT and Gd-DTPA solutions were aligned in a 
single row at the iso-center of the magnetic bore, with the cylinder axis perpendicular to 
the main magnetic field. A standard quality assurance ball-shaped MRI phantom from the 
manufacturer was used and placed on top of the solution phantoms to ensure proper 
shimming. To obtain the relaxation curve for T 1 value calculations, a 2D gradient echo 
sequence (GRE) (matrix = 256 x 256, FOV = 30cm, alpha = 90°, NEX = 1) with TE = 6 
ms and various TRs (18 ms, 25 ms, 50 ms, 100 ms, 150 ms and 200 ms) were used 
consecutively. The maximum TR of 200 ms was chosen based on prior knowledge that it 
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allowed full recovery of longitudinal magnetization. A single slice of 10 mm thickness 
cut across all samples perpendicular to their cylinder axis was obtained for each TR. The 
mean signal intensity of each phantom at each TR was determined by drawing a circular 
region of interest (ROI) of equivalent size on each phantom. The background image noise 
was obtained by drawing 64 x 64 pixels ROI at the image background, and was fitted and 
suppressed from the mean signal intensity of each phantom with a Rician distribution 
noise model. The mean ROI signal intensity of each phantom was used in the 
determination of the TJ value, if the measurement was not at noise level (p < 0.05). To 
obtain the relaxation curve for T 2 value estimation, a spin echo sequence (SE) was 
employed with a fixed TR = 1000 ms and various TEs (6.5 ms, 7 ms, 8 ms, 10 ms, 20 ms, 
25 ms, 50 ms, and 100 ms). The same slice orientation and mean signal intensity 
measuring method was used to obtain the relaxation curve for T 2 value estimations. 
Cell Labeling and Imaging with GNTs 
A NIH 3T3 mouse fibroblast cell line was cultured at 37°C and 5% CO2 in 100 x 
20 mm tissue culture dishes using standard cell culture media, containing Dulbecco's 
Modified Eagle Medium (DMEM, Invitrogen) with 10% fetal calf serum (FCS, 
Invitrogen) and 1% Penicillin-Streptomycin (SIP, Fisher Scientific). For cell labeling 
experiments, 107 cells/well were plated for 24 hours to allow cell adhesion. The cells 
were then incubated with GNT solution diluted with the standard culture media (final 
[Gd] = 0.01 flM, 0.025 flM, 0.5 flM, 1.0 flM, and 5.0 flM) for 24 hours. The labeled cells 
were then washed twice with phosphate-buffered saline (PBS, Invitrogen) to remove any 
excess GNTs that might be adsorbed on the cell membrane. The labeled cells (- 2.5 X 
107) were resuspended in 1.2 mL of PBS and centrifuged at 1000 rpm for five minutes to 
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make a pellet. The cell pellets were imaged in a 15 mT scanner using TRITE = 120/25 ms 
and NEX = 64. Unlabeled cell pellets were used as a control. 
RESULTS AND DISCUSSION 
Magnetic Characterization in a 0.2 T Clinical MRI Scanner 
Figure 8 represents the T I-weighted MRI phantoms of GNTs along with clinical 
MRI CA, Magnevist®. All the three GNT samples exhibit a very strong T I effect, as 
observed by the increase in image intensities with increasing TR (the time interval 
between successive RF pulses applied on the same sample slice). The effect is more 
pronounced for individual GNTs and GadoDex, where the image intensities are much 
brighter. In contrast, Magnevist® showed no observable contrast enhancement. The lack 
of enhancement is more significant considering that the [Gd3+] in Magnevist® (20 mM) 
is ~ 200 - 500 times greater than that of GNTs. 
Bundled Gadonanotubes 
Individual Gadonanotubes 
GadoDex 
Magnevist® 
18 25 50 100 150 200 
TR(ms) 
Figure 8. T rweighted phantom images of GNTs compared with the clinically-used MRI CA, 
Magnevist®, in a 0.2 T scanner at 25°C. 
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However, the image intensities in Figure 8 are not the true representation of the 
relaxation efficacy (relaxivity) of the sample. The image intensities are dependent on the 
concentration, and all the samples have different Gd3+-ion concentrations. In order to 
compare their efficacy, their TI-shortening (contrast enhancement) properties have to be 
normalized for the Gd3+-ion concentration. The efficacy, which is normalized for Gd3+-
ion concentration, is called relaxivity (rl ,2; mM-Is- I) and is calculated using the expression 
rI ,2 = R I,2 -Ro/[CA], where RI is the relaxation rate (l/TI; S-I) of water protons in the 
presence of CA, and, Ro is the relaxation rate in the absence of CA, and [CAl is the 
concentration of CA in mM.32 The T I values of all the four samples were calculated from 
the mean signal intensities (Si) from Figure 8 using the equation, Si = So. (l - e-TRff I ). So 
is the signal intensity at equilibrium state; TR is the repetition time of RF pulses. All of 
the fits in Figure 9 exhibited R2 values ~ 0.99, suggesting a good fit to the experimental 
data. 
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Figure 9. Fitting of signal intensities for T I calculation of GNTs and Magnevist® at 0.2 T. 
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Table II. Comparative relaxivities of Gd-based MRI CAs at 0.2 T. 
Sample [Gd] mM Tl (ms) T2(ms) rl (mM-1s-
1) r2 (mM-1s-1) 
r2/r l 
per Gd3+ ion Gd3+ . per Ion 
Bundled GNT 0.104 22.64 28.57 418 314 0.75 
Individual GNT 0.083 31.60 38.46 373 285 0.76 
GadoDex 0.039 31.14 70.42 806 303 0.37 
Magnevist® 20 12.94 8.5 3.8 5.8 1.52 
As can be seen from Figure 9 and Table II, GNTs have a dominant T I-shortening 
effect at low-fields. Their relaxivity values suggest that GNTs are better than the current 
clinically-used agent by at least two orders of magnitude. A T I-weighted CA is required 
to have a more pronounced effect (r2/rl < 2) on the longitudinal relaxation (T I-shortening) 
of water protons than on their transverse relaxation (T 2-shortening). 32 All the Gd-based 
CAs compared in the above studies are good T I-weighted CAs; however, GNTs are much 
better than Magnevist@. The r2/rl ratio for GNTs makes them attractive candidates for 
cellular and molecular imaging using TI-weighted MR.I at low-fields. In addition, the 
exceptionally large relaxivities of GNTs suggest that even a smaller concentration of 
GNTs can produce higher contrast when used at low fields. This effect is especially 
pronounced for GadoDex, since its relaxivity (806 mM-Is-1 per Gd3+ ion) is the greatest, 
by far, ever reported for any Gd-based CA under any conditions! 
Cellular Imaging at 15 mT MRI Scanner 
For the cell labeling experiments, individual GNTs are preferred over bundled 
GNTs because of sample homogeneity. However, as with many other low-field scanners, 
the 0.2 T scanner we used was discarded for the want of space. Hence, most of the 
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previous low-field data had to be recollected with the 15 mT scanner available at 
National Institutes of Health (NIH), Bethesda, Maryland. Unlike the 0.2 T scanner (a 
commercial scanner), the new 15 mT scanner was a custom built scanner designed for 
hyperpolarized MRI studies. As a result, the pulse sequences and other imaging 
parameters were limited. Before cell labeling and imaging using GNTs, the efficacy of 
individual GNTs dispersed in Pluronic surfactant was first tested at 15 mT. The phantom 
image ofGNTs and Magnevist® at 15 mT is presented in Figure 10. 
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Figure 10. T rweighted phantom images (15 mT) of individual GNTs and Magnevist@ at 
different Gd3+-ion concentration. The measurements were performed at room 
temperature. 
GNTs exhibited better contrast enhancement than Magnevist® at 15 mT, 
reiterating their superior T1-shortening properties at low-field strengths. However, the 
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relaxivity of individual GNTs at 15 mT were significantly lower (~ 50 %) than the 
relaxivity values at 0.2 T (Figure 11). 
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Figure 11. Relaxivity (rt) calculation of individual GNTs and Magnevist® at 15 mT and 
comparison of relaxivity values for 0.2 T and 15 mT. 
The observed difference in relaxivities between the 0.2 T and 15 mT magnetic 
fields is most likely due to the difference in the image acquisition parameters for the two 
instruments. The 0.2 T scanner used was a commercial unit. Hence, it has many 
optimized pulse sequences compared to the 15 mT scanner used for the most recent 
studies. In spite of reduced relaxivities at 15 mT, GNTs are still --20 times more 
efficacious than Magnevist®. This has significant importance as the current trend in low-
field MR imaging is to use twice the concentration of Gd-based CAs to obtain similar 
resolution as that of high-field instruments.26, 27 
In order to test the efficacy of GNTs to act as cell labeling and imaging agents at 
low-fields, mouse fibroblast cells (NIH 3T3) were labeled with GNTs. The inherent 
lipophilicity of GNTs enabled efficient cell labeling without the aid of trans feet ion agents 
21 
or advanced cell labeling techniques. A control phantom with unlabeled fibroblast cells 
was also imaged at 15 mT. Different incubation concentrations of individual GNTs 
resulting in final Gd3+-ion concentration of 0.01 JlM, 0.025 JlM, 0.1 JlM, 0.5 JlM, and 5 
JlM were used. At higher incubation Gd3+-ion concentrations (0.1 JlM, 0.5 JlM, 5 JlM), no 
contrast enhancement in GNT-Iabeled cells was observed (Figure 12). In fact, the GNT-
labeled cells appeared darker than unlabeled control cells, suggesting a dominant T 2 * 
(spin-spin relaxation) effect. Interestingly, at lower incubation Gd3+-ion concentrations 
(0.025 JlM, 0.010 JlM), the GNT -labeled cells appeared brighter than unlabeled cells. 
Figure 12. T rweighted MRI phantom images of GNT -labeled cells at 15 mT for different 
incubation Gd3+ -ion concentrations. 
The T 2 * effect observed at higher incubation concentration is likely due to dense 
packing of GNTs inside the cells. In a separate experiment (result not shown), we 
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demonstrated that the amount of GNTs localized within a cell is directly proportional to 
the incubation concentration. Hence, at higher incubation concentration, more GNTs will 
be present within the cell resulting in a dense packing. Such close packing of CAs have 
previously been shown to result in susceptibility effects leading to greater enhancement 
in T 2 * effect in superparamagnetic iron-oxide labeled cells.33-35 The superparamagnetic 
nature of GNTs (see Chapter 4) suggests that such a mechanism is possible for GNT-
labeled cells as well. At lower incubation Gd3+-ion concentrations (0.01 /-lM, 0.025 /-lM), 
the GNTs localized within the cell should experience less aggregation. In such cases, the 
susceptibility-induced T2* effect should be less pronounced leading to enhanced contrast 
of labeled cells compared to control cells (Figures 12 and 13). 
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Figure 13. Trweighted contrast enhancement for GNT-labeled cells as a function of 
incubation Gd3+ concentration at 15 mT and 37°C. 
The enhancement in contrast at lower Gd3+-ion concentration when intracellularly 
localized is an interesting and very useful property of GNTs. Current cellular and 
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molecular imaging using MRI mainly revolves around superparamagnetic iron oxide 
based T2-weighted CAs. To be able to visualize the cells using MRI and track them in 
vivo, extensive labeling (-20 pg Fe/cell) is required.3o In such a scenario, after a few cell 
division cycles, the iron concentration becomes too diluted to enable further tracking of 
labeled cells. Our results suggest that GNT -labeled cells can initially be imaged using T 2-
weighted MRI and then, even after multiple cell divisions, can still be tracked using their 
very efficient T I-shortening properties at lower concentrations. The ability to image the 
same CA based on two different relaxation mechanisms by altering their intracellular 
concentration is hitherto unknown for any MRI CAs and is a potential advantage for 
GNTs that needs further investigation. 
CONCLUSION 
Low-field MR imaging has long suffered from low SNR that limits its use in 
clinical diagnosis. GNTs with their extremely large longitudinal relaxivities (as high as 
800 mM-I-s-I) offer a new paradigm in contrast-enhanced low-field MRI. The lipophilic 
nature of GNTs provides them with the ability to translocate through the cell membrane 
without the aid oftransfection agents or other advanced cell-labeling techniques. The cell 
labeling efficiency and the superior low-field relaxivities of GNTs projects a new class a 
TI-weighted CAs for cellular and molecular imaging. If translated to real-time imaging 
applications, the observed contrast enhancement with lower intracellular Gd3+ 
concentration may well lead to a new class of MRI CAs with the potential for long-term 
in vivo tracking in stem cell therapy and drug delivery applications. 
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CHAPTER 3 
Dextran-coated Individual Gadonanotubes (GadoDex) as CAs for MRI 
Need for Biocompatible. Protein-resistant Coating 
GNTs exhibit longitudinal relaxivities (- 170 mM-Is-I) 40-50 times greater than 
clinically-used Gd-chelates (- 4 mM-Is-I).18 GNTs also show unprecedented pH 
sensitivity which could help in the early detection of disease_ 36 The hydrophobic nature of 
the single-walled carbon nanotube (SWNT) necessitates the use of surfactants/polymers 
to disperse GNTs for biological applications. A variety of surfactants and synthetic 
polymers have been proposed for the dispersion of SWNTs.37 A biocompatible Pluronic® 
(PEO-PPO block copolymer) has been successfully used for GNT dispersion. However, it 
has been shown that the Pluronic coating is replaced very quickly by proteins in the 
bloodstream.38 Such fast adsorption of proteins on the SWNT surface is not ideal for the 
development of GNTs as vascular agents or targeted MR imaging. For a successful 
vascular agent and targeted delivery, it is important that the agent stays in the 
bloodstream for longer time periods (longer blood circulation time). For achieving long 
circulation times, many natural and synthetic polymers have been proposed and studied. 
Dextran, a polysaccharide made of sucrose units, has been shown to have a protein-
resisting surface.39, 40 It is also used to solubilize iron oxide for use in MRI.41 In this 
Chapter, the development of dextran-coated GNTs (GadoDex) and their efficiency as a 
longitudinal MRI CA is reported. 
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MATERIALS AND METHODS 
Synthesis of GadoDex 
GNTs (bundled and individual) were synthesized using the protocol detailed in 
Chapter 2. Dextran with an average molecular weight of 9,000-11,000 Da was 
purchased from Sigma-Aldrich (St Louis, Mo). As obtained dextran was carboxylated 
using a procedure reported by others.42 Briefly, 2 g of dextran was dissolved in 10 mL of 
DI water. To this, 0.2 mL of 40 % NaOH was added and the solution was refluxed for 45 
minutes. The solution was then allowed to cool down to room temperature and the 
carboxylated dextran was precipitated using methanol (Figure 14). 
HO ~OH 0 
HO [:ha] 
OH~ o 
HO 
HO OH 
OH 
Figure 14 Schematic representation of the synthesis of carboxylated dextran. 
Individual GNTs (25 mg) were then refluxed with 25 mL of carboxylated dextran 
solution in DI water for 45 minutes. The resulting suspension (GadoDex) was then probe-
sonicated for 2 minutes and allowed to settle overnight. The solution was centrifuged at 
3,200 rpm for ten minutes to remove large aggregates and unwrapped GNTs. The 
supernatant was then dialyzed against running water (50,000 MW cutoff membrane) for 
three days to remove any unreacted carboxylated dextran. 
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Characterization 
The solubility measurements were carried out in a UV-Vis spectrometer. For 
solubility measurements, known amounts of lyophilized GadoDex were dissolved in a 
known volume of water. The absorbance spectrum was collected for different 
concentrations of GadoDex in solution. The maximum solubility was taken as the 
concentration at which the absorbance ceased to increase linearly with increasing 
GadoDex concentration. The atomic force microscopy (AFM) imaging was then 
performed using a Nanoscope II instrument. Typically, 20 ilL of the GadoDex solution 
(5mg/mL) was spin-coated on a mica disc and used for the imaging studies. Transmission 
electron microscopy (TEM) images were taken with a JEOL 2010 transmission electron 
microscope using a lacey carbon grid. 
The Gd3+-ion concentration was measured using inductively-coupled plasma-
optical emission spectrometry (ICP-OES). The samples for ICP-OES measurements were 
prepared by digesting a known volume of GadoDex with 90 % RN03 (heated carefully to 
dryness) followed by 30 % H202. The solid residue thus obtained was dissolved in 2% 
RN03 and used for ICP measurements. 
The relaxation measurements were performed using a bench-top relaxometer 
(Bruker Minispec mq 60) at 60 MHz and at 37°C. An inversion recovery pulse sequence 
was used for longitudinal relaxation time (T 1) measurements. 
Nuclear Magnetic Relaxation Dispersion (NMRD) Profile 
NMRD measurements were performed using a Stelar Spinmaster FFC fast field 
cycling relaxometer covering a continuum of magnetic fields from 2.35x10-4 to 0.47 T 
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(corresponding to proton larmor frequency of 0.01 - 20 MHz) equipped with a VTC 90 
temperature control unit. For relaxivities at higher fields, Bruker Minispec mq30 (30 
MHz), mq40 (40 MHz) and mq60 (60 MHz) and Bruker 1.18 T (50 MHz), 2.35 T (100 
MHz) and 4.70 T (200 MHz) cryomagnets connected to a Bruker A vance-200 console 
were used. 
Phantom Measurements in Clinical Scanner 
Clinical MRI phantom measurements were performed with a 3 T Intera MRI 
system (Philips Medical Systems, Best, Netherlands) with a Quasar gradient system 
(Philips Medical Systems). For Tl measurements, mUltiple inversion recovery sequences 
were used with identical TE and varying inversion time (TEITRITI = 10/10000/200, 400, 
800, 1000, 1500, 2000, 2500, 3000, 4000, 5000 ms). Each image was acquired in the 
coronal plane with 128 x 128 matrix over a 150 mm x 150 mm FOV, with slice thickness 
of 3 mm. Slice locations for T 1 were reproducibly placed at the same locations in the 
phantom using a high-resolution 3D magnetization-prepared rapid gradient echo 
(MPRAGE) sequence for localization. 
RESULTS AND DISCUSSION 
Characterization of GadoDex 
Full-length SWNTs have been shown to be very well-dispersed in a 1 % dextran 
solution.43 In our studies, bundled GNTs also dispersed well in the aqueous dextran 
solution. Biological applications involving SWNTs require homogeneous distribution. 
Hence, individual GNTs (predominantly single tube or small bundle of 2-3 tubes) were 
prepared in the same way as that of bundled GNTs. Interestingly, individual GNTs lacked 
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solution stability when sonicated with an aqueous solution of dextran (2% (w/v) in DI 
H20) and precipitated quickly after sonication. To achieve a stable dispersion of 
individual GNTs coated with dextran, it was decided to try carboxylated dextran. 
Carboxylated dextran has been widely used to solubilize iron oxide-based CAs. Dextran-
coated iron oxide particles are commercially used for imaging liver and spleen and are 
currently in clinical trials for other imaging applications.4I, 44 The carboxyl groups on the 
dextran molecule interact strongly with the iron atoms on the surface of the iron oxide 
nanoparticles to form a stable dispersion for biological applications.42 Our hypothesis is 
that such interactions are also possible with GNTs since Gd3+ ions (located at the defect 
sites in GNTs) are known to be strongly chelated by the carboxyl groups. Upon refluxing 
GNTs with a carboxylated-dextran solution, followed by sonication, a stable dispersion 
of individual GNTs (GadoDex) resulted. We believe that this stable dispersion is likely 
due to the interaction between the carboxyl groups of dextran and the Gd3+ ions of GNTs. 
Carboxylates have long been known as excellent chelators for metal ions and many of the 
current Gd-based clinical MRI CAs are polyaminocarboxylate complexes of Gd3+.10 The 
likelihood of carboxylate-Gd3+ interaction in GadoDex is further corroborated by the 
observation that individual US-tubes (no Gd3+ ions) lacked stability in solution when 
refluxed with a carboxylated-dextran solution. The potential downside of carboxylate-
Gd3+ interaction is that strong chelation of Gd3+ ions might result in possible leakage of 
Gd3+ ions from US-tubes. It is believed that the Gd3+-ion clusters are central to the 
superior relaxivity exhibited by GNTs over other clinically-used paramagnetic Gd-based 
MRI CAs. IS To confirm the stability of the Gd3+-ion clusters in GadoDex, we analyzed 
the washings from the dialysis of GadoDex by ICP-OES. If Gd3+ ions leaked from GNTs 
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due to strong carboxylate-Gd3+ interactions, they should be removed by the dialysis 
process due to their small size. No such leakage of Gd3+ ions was detected by ICP-OES 
measurements (sensitivity 1 ppb). The dialyzed GadoDex was also characterized for its 
magnetic properties. The SQUID magnetic measurements post-dialysis showed that 
GadoDex retained the superparamagnetic nature of the original GNTs (Figure 15). 
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Figure 15. Magnetic characterization of GadoDex at 310 K, demonstrating 
superparamagnetism. 
Once the stability of Gd3+-ion clusters in GadoDex was confirmed, the sample 
was characterized by AFM and TEM. The AFM image of GadoDex showed a thickness 
of about 16-20 om and a length of about 120 nm (Figure 16). The length of GadoDex is 
longer than the expected length of GNT alone (20-80 om). This difference in the length 
can be attributed to the flattening of the AFM sample on the mica stub. The TEM image 
of the sample showed a similar thickness of 20 om (Figure 17). The microscopy images 
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confirmed the presence of a single GNT or very small aggregate (2-3 tubes) of GNTs in 
each of the GadoDex entity. 
Figure 16. AFM image of a GadoDex sample with its section analysis. 
Figure 17. TEM image of GadoDex. 
GadoDex exhibited a high degree of dispersibility in water (> 14.5 mg/mL). Due 
to the larger molecular weight of dextran (9,000-11 ,000 Da), the value may not 
necessarily translate into greater dispersity for GNTs. Thermogravimetric analysis (TGA) 
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of GadoDex showed that nearly 70% (w/w) of GadoDex is composed of carboxylated 
dextran (Figure 18). Using TGA and UV-Vis data, it can be estimated that the 
carboxylated-dextran coating resulted in the dispersion of 4.4 mg/mL of GNTs in water. 
This value is comparable to the dispersibility of SWNTs by SDBS (3.6 mg/mL)/7 
demonstrating the superior dispersion ability of carboxylated-dextran. Thus, the benign 
pharmacological properties of the dextran coating provide an effective and biocompatible 
dispersion medium for GNT MRI CAs 
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Figure 18. Thermogravimetric analysis for GadoDex. 
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MRI Relaxation Properties of GadoDex 
Once a stable dispersion of GadoDex in water was obtained, the proton relaxation 
property of the sample was characterized. The relaxivity measurements were performed 
using a bench-top relaxometer at 60 MHz and 37 °C, and an inversion recovery pulse 
sequence was used to measure the longitudinal relaxation time (TI). The longitudinal 
relaxivity (rl) values of GadoDex and individual GNTs dispersed in sodium dodecyl 
benzene sulfonate (SDBS) surfactant are presented in Table III. Both of the GNTs 
exhibited similar relaxivities. When compared to Magnevist®, the GNTs are - 20 times 
more efficacious. In order to verify the bench-top relaxometer results with a clinical 
scanner, GadoDex was tested in a 3 T scanner, along with Magnevist®. The results from 
the clinical scanner also confirmed the superior efficacy of GadoDex over Magnevist® 
(Figure 19). 
Table III. Comparison of longitudinal relaxivities for GNTs and Magnevist@. 
Measurements were performed at 60 MHz and 37 °C. 
Sample Relaxivity (mM-1s-1) per Gd3+ ion 
Bundled GNT (SDBS-coated) 173 
Individual GNT (SDBS-coated) 77.0 
GadoDex 74.7 
[Gd(H20 )8]3+ 8.4 
Magnevist® 3.7 
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Figure 19. Inversion recovery graphs of GadoDex and Magnevist® (both at [Gd3+] = 0.038 
mM) in a clinical 3 T scanner. 
Understanding the NMRD Profile for GadoDex 
We now know that GadoDex has promising properties as an MRI CA and is more 
efficacious than current Gd-chelates. However, it is important to understand the 
parameters affecting the relaxivity of GadoDex to optimize their performance further. 
Measuring the relaxivity of a CA as a function of magnetic field (Nuclear Magnetic 
Relaxation Dispersion (NMRD)) is a valuable tool for the separation of different 
interaction mechanisms and dynamic processes affecting the relaxation behavior.32 Thus, 
the NMRD profile for aqueous solution of GadoDex was recorded at 37°C (Figure 20). 
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Figure 20. Nuclear magnetic relaxation dispersion (NMRD) profile for GadoDex at 37°C. 
The shape of the NMRD profile of GadoDex resembled that of bundled GNTs but 
with lower relaxivity at all field strengths. Due to the very high relaxivities at low-field 
strengths and the shape of curve at low-fields for GadoDex, the entire profile cannot be 
fitted by the standard Solomon-Bloembergen-Morgan (SBM) theory for proton relaxation 
by Gd-based CAs. However, the theoretical predictions using SBM theory can quite 
accurately reproduce the experimental NMRD profile in the medium-to-high field regime 
(VI> 10 MHz), which is the clinically-relevant range (Figure 21). 
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Figure 21. Theoretical fitting of the NMRD profile for GadoDex. 
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If it is assumed that the inner-sphere contribution to rl relaxivity dominates the 
outer-sphere contribution (rl os / rl IS < 1) for GadoDex, as is the case for slowly rotating 
CAs with large reiaxivity,45 the fitting of the NMRD profile depends on the number of 
inner-sphere water molecules (q), the molecular tumbling time of the Gd-CA with the 
inner-sphere water molecules (rR), the proton exchange rate ('tm), and the Gd3+ ion-water 
proton bond distance (rGd-H). Using this assumption, the best fit was obtained for q = 2, 'tR 
= 100 ns, 'tm = 1.5 ns, rGdH = 0.31 nm, with the values for other parameters as listed in the 
Table IV. The accuracy of the fitting is clearly shown in the inset of Figure 21. 
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Table IV. Various parameters used for fitting the NMRD profile of GadoDex. 
Parameter Value 
q 2 
! 
'tR 100 ns 
'tm 1.5 ns 
rGd-H 0.31 nm 
'tv 10 ps 
fl2 5 X 10 18 S-2 
The characteristic 'tR value used for the fitting is considerably longer when 
compared to general Gd-polyaminocarboxylate CAs so far studied (Table V). However, 
this -'tR value is not unreasonable, given that for a spherical CA of radius a = 5 nm 
tumbling in aqueous solution, the characteristic 'tR is about 100 ns, and larger values can 
be estimated for a cylindrical nanoparticle (GadoDex is ~ 100 nm long and 20 nm in 
diameter). As regarding the other fitting parameters (except for q, 'tR and 'tm as discussed 
above), their values fall within the ranges normally observed for Gd-based CAs. When 
compared to traditional Gd-chelates, a significant difference for GadoDex is observed for 
both the molecular tumbling time ('tR) and the proton-exchange rate ('tm) (Table V). Both 
of these parameters are certainly due to the US-tube component of GadoDex, reiterating 
their importance in MRI relaxation of GadoDex. However, it is surprising that q = 2 is so 
low for GadoDex, since the potential coordination number for the naked Gd3+ ions within 
GNTs is 8-9. Some of the coordination sites might be occupied by possible hydroxyl 
bridges between Gd3+ ions in the GNTs (and are probably responsible for maintaining the 
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Gd3+-ion clusters even when physiologically challenged). In addition, the hydrophobic 
inner surface of US-tubes might prevent the access of water protons to certain 
coordination sites. In spite of these possibilities, a greater number (4-6) of inner-sphere 
water molecules (q) was expected for GadoDex to account for their superior relaxivity. It 
is presently believed that the lower value of q = 2 from NMRD profile fitting, is likely 
due to the coordination of the carboxyl groups of dextran with Gd3+ ion clusters. Thus, 
one of the possible ways to improve the relaxivity of GadoDex further would be to 
covalently functionalize the US-tube surface with dextran, thereby increasing the number 
Gd3+-ion coordination sites available for proton exchange. 
Table V. Comparison of parameters from fitting NMRD profiles for various Gd-based MRI 
CAs. 
Compound TR Tm 
rl (mM-1s-1) per 
q 
Gd3+ ion 
Magnevist® 54 ps 143 ns 1 3.4 
Dotarem® 53 ps 122 ns 1-2 3.1 
[Gd(H1O)S]3+ - 1.2 ns 8-9 8.4 
-, 
Gadonanotu bes 100 ns 1.5 ns 2 ~ 100 
Interestingly, the rl relaxivities of individual GNTs (regardless of the nature of the 
surfactant) dropped by ca. 50 % when compared to bundled GNTs (Table III). The 
observed decrease in longitudinal relaxivity can be attributed to the debundling 
procedure. As we have seen above, the longitudinal relaxivity of GNTs is determined by 
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the number of inner-sphere water molecules (q), the molecular tumbling time of the CA 
(tR), and the proton exchange rate (tm) of inner-sphere water molecules of the CA with 
bulk water molecules. Debundling of GNT aggregates by the NaolTHF method results in 
lower molecular-weight individual GNTs which might tumble faster than higher 
molecular-weight bundled GNTs. In addition, water molecules can get trapped in the 
interstices of the GNT aggregates, leading to a different diffusion rate and proton 
exchange rate. Such aggregate-dependent relaxation enhancement mechanisms have 
previously been reported for gadofullerenes.46 Another significant difference between 
bundled GNTs and GadoDex is the fall-off of relaxivity at higher field strengths (to only 
21 mM-1s-1 at 4.7 T) for GadoDex, whereas, the relaxivity of bundled GNTs plateaus at 
field strengths above 1.41 T. This phenomenon cannot be explained with current results 
and will require carefully designed studies to understand in detail. Also, the lack of 
stability of GadoDex in phosphate-buffered saline (PBS) (visible precipitation in 1 hour) 
needs to be overcome for long-term in vivo and molecular imaging studies. Possibly, the 
lack of stability in PBS of GadoDex (due to the weak interaction between the Gd3+ - ion 
cluster and carboxylated dextran) can be overcome by covalently attaching the dextran 
component to the GNT sidewalls. 
CONCLUSION 
In summary, we have developed a biocompatible carboxylated-dextran coating for 
the dispersion of GNTs. The carboxylate groups of dextran likely forms a weak bonding 
interaction with the Gd3+-ion clusters available at the defect sites of GNTs to provide 
dispersibility. The aqueous dispersibility of GadoDex (4.4 mg/mL) is comparable to that 
of SDBS-coated SWNTs. GadoDex retains the superior contrast enhancement efficacy of 
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GNTs and exhibits greater relaxivities at all field strengths compared to commercially-
available Gd-based agents. Their very high relaxivities at low-field strengths make 
GadoDex an attractive candidate for low-field MR!. The theoretical fitting of the NMRD 
profile of GadoDex attributes the observed high relaxivities to the synergistic effect of 
increased tR and tm when compared to Gd-chelate CAs. The fitting of the NMRD profile 
also demonstrates the important role played by the US-tube component of GadoDex. The 
relaxivity may further be enhanced for GadoDex by covalently functionalizing the 
external surface of GNTs with dextran, thereby increasing the number of inner-sphere 
water molecules in the Gd3+-ion clusters. 
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CHAPTER 4 
Part A: Gadonanotubes as T 2-weighted MRI CAs 
Brief Introduction to T rweighted MR Imaging 
Contrast agents for MRI are classified into two categories: 1) CAs that shorten the 
spin-lattice relaxation rates of water protons (TI-weighted CAs) and 2) CAs that shorten 
the spin-spin relaxation rates (T2-weigthed CAs). The TI-mechanism involves interaction 
(direct and indirect) with the surrounding protons. Hence, most of the T I-weighted CAs 
(mainly Gd-complexes) have direct exchange with the water protons in its vicinity 
(Figure 3). The T 2-mechanism is more dependent on the magnetic properties of the CAs 
than on their proton exchange properties. Both TI-weighted and T2-weighted proton 
relaxation require respective CAs to have magnetic properties, hence, a T I-weigthed CA 
will have T 2-shortening properties and vice versa. A CA is labeled as a T I-weighted CA 
or a T 2-weighted agent based on the dominant effect (relaxivity; rl,2) of one of the two 
mechanisms. If r2/rl S 2, then the agent will be a T I-weigthed CA; if r2/rl > 2, then the 
agent acts as a T 2-weighted CA.32 
GNTs have shown contrast enhancement efficacy at least 40 times better than 
current clinically-used Gd-based CAs such as Magnevist® (Table III) at a clinically 
relevant field strength of 1.41 T. Their T I-contrast enhancement is due to the presence of 
encapsulated Gd3+-ion clusters in the hollow interior of the US-tubes. However, their 
superparamagnetic nature (Figure 22) suggests that they can also act as T 2-weighted 
CAs. In this chapter, we discuss the possibility of GNTs to act as T2-weighted MRI CAs 
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at higher magnetic field strengths and their use as labeling agents for cell ular and 
molecular imaging. 
Q11 ~----------------------------____________ __ 
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Figure 22. Zero-field-cooled and field-cooled (ZFC+FC) curve for GNTs demonstrating 
their superparamagnetism. Reproduced with permission Ref. 18. 
MATERIALS AND METHODS 
Relaxometry Measurements 
Individual GNTs were synthesized using the procedure detailed in Chapter 2. The 
T2-proton relaxation studies were performed on a Bruker Minispec mq series (30, 40, and 
60 MHz) and on Bruker NMR spectrometers (100, 200, and 400 MHz) using Carr-
Purcell-Meiboom-Gill (CPMG) sequence. Relaxivity measurements were also performed 
in a clinical 3 T MRI system (General electric, Milwaukee, WI). The transverse 
relaxivities (r2) of the samples were measured by a Hahn spin-echo sequence with TR = 
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500 ms, TE = 10 ms, Ilms, 12 ms, 13 ms, 14 ms, 15 ms, 25 ms, 50 ms, 75 ms, and 100 
ms. T 2 of each phantom was obtained by linear fitting of logeS) = log (So) - TE / T 2. 
RESULTS AND DISCUSSION 
Transverse Relaxation Properties of Gadonanotubes 
The transverse relaxation rates (R2) of GNTs at different proton Larmor 
frequencies are presented in Table VI. The transverse relaxation time (T 2; as a result R2) 
are dependent on the concentration of the CA. In order to compare GNTs with other T 2-
weighted MRI CAs, it is necessary to compare their relaxivity, which is normalized for 
concentration. The transverse relaxivity (r2) of GNTs are calculated as a function of Gd3+ 
concentration and is also presented in Table VI. 
Table VI. Transverse relaxivities (r2) of GNTs at different proton Larmor frequencies. 
Measurements were performed at 37 °c. 
Relaxivity (r2) 
Larmor frequency 
Relaxation Rate (S-l) [Gd3+] mM mM-1s-1 per Gd3+ 
(MHz) 
ion 
30 14.27 0.035 403 
40 15.32 0.035 434 
60 15.68 0.035 444 
100 14.71 0.035 416 
200 14.49 0.035 410 
GNTs showed exceptionally large transverse relaxivities at all field strengths. 
When the transverse relaxivity (r2) of GNTs is compared to their longitudinal relaxivity 
(rl) at a clinically-relevant field strength of 1.41 T, the data indicates that GNTs are 
strong T2-weighted MRI CAs (Table VII). For comparison, relaxivity for a clinically-
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used iron oxide-based MRI CA (for T2-weighted imaging),47 and a Gd-based agent (for 
T ,-weighted imaging) 10 are also presented in Table VII. GNTs far outperform 
Ferumoxtran® in their transverse relaxivity and Magnevist® in their longitudinal 
relaxivity. 
Table VII. r2/rl ratio for GNTs at 1.5 T and 37°C. For comparsion, relaxivity values for 
clinically-used Magnevist® and Ferumoxtran® are also presented. 
Sample rl relaxivity (mM-Is-I) r2 relaxivity (mM-Is- r2/rI 
per Gd3+ ion 1) per Gd3+ ion 
Magnevist® 3.4 4.5 1.3 
Gadonanotubes 97 444 4.6 
Ferumoxtran® 10 (based on [Fe]) 65 (based on [Fe]) 6.5 
To confirm that the observed exceptionally large transverse relaxivity of GNTs 
can be reproduced in a clinical scanner, we tested GNTs in a high-field (3 T) clinical 
scanner. GNTs retained the high transverse relaxivity in a clinical scanner (424 mM-'s-'). 
However, as observed in the NMRD profile of GadoDex (Figure 20), their longitudinal 
re1axivity (68 mM-1s- I ) is significantly lower than at 1.5 T (97 mM-'s-'). The reduction in 
longitudinal relaxivity further increases the r2/r, ratio (from 4.58 at 1.5 T to 6.5 at 3 T), 
making GNTs an attractive candidate for cellular and molecular imaging using T r 
weighted MRI at higher magnetic field strengths. This is counterpoint to our longstanding 
belief that GNTs are superior Tt-weighted CAs at low fields (mT to 3 T) and a high-
performance T2-weighted CAs at higher field strength (> 3 T). In order to better 
understand the transverse relaxivity of GNTs, we performed a control of US-tubes alone 
(with no Gd3+ ions). Previously, it was reported that the US-tubes alone do not have an 
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appreciable TI-relaxation property.18 However, T2-relaxation measurements showed that 
US-tubes are excellent T 2-weighted CAs, even in the absence of any Gd3+ ions. The T 2-
shortening properties of the empty US-tubes can be attributed to the metal catalyst 
particles (Y, Ni in arc-discharge tubes) used in the synthesis of SWNTs. Even though the 
cutting process removes the majority of the catalyst, some of it still remain with the US-
tubes (ca. 2% Ni & 0.6% Y) and there are other metal catalyst impurities like iron « 
0.1 %) also present. These metal catalyst particles have inherent magnetic properties, thus 
producing transverse relaxation for empty US-tubes. Since most of these metal particles 
are likely buried under a hydrophobic carbon sheath, they have little or no interaction 
with water protons. This likely explains the absence of any longitudinal relaxivity (T 1-
relaxation) for empty US-tubes. With these results in hand, the r2/rlvalues presented in 
Table VII may not reflect the actual relaxation behavior for GNTs. 
Delineating the contribution from Gd3+ ions on the transverse relaxation rate (T 2-
relaxation) of GNTs is complicated by the lack of data about the molecular weight of the 
US-tubes. However, the amount of US-tubes present in a stable GNT suspension used for 
the relaxivity measurements can be calculated using the metal catalyst and Gd3+ ion 
concentration. Using this method, a solution was prepared with empty US-tubes having 
the same amount of US-tubes as in GNT solution. In order to make a homogenous 
solution, known quantities of each of the two samples (US-tubes and GNTs) in the 
absence of surfactant were analyzed for their metal catalyst (Ni, Y, Fe & Gd) content by 
ICP-OES. The ICP measurements (agreement within 2%) were run in triplicate to 
determine the average metal content in each sample. Then the two samples dispersed in 
Pluronic® surfactant were analyzed for their metal content, and, from these values, the 
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amount of US-tubes present in each of the sample was determined. The US-tube sample 
was then diluted such that the concentration of US-tubes in both the sample was the 
same. The T 2-relaxation time of both the samples were measured in a bench-top 
relaxometer (60 MHz; 37°C). The T2-relaxation time of empty US-tube sample was 
subtracted from that of GNTs. The difference in relaxation times between the two 
samples was attributed to the actual transverse relaxation effect from Gd3+ ions (Table 
VIll). 
Table VIII. Delineating the contribution of Gd3+ ion on the relaxivity of GNTs. 
Measurements were performed at 60 MHz and 37°C. 
Our method for determining the contribution from Gd3+ ion may not be the ideal 
procedure, since the presence of paramagnetic Gd3+ ions inside the US-tubes might lead 
to magnetic coupling between the metal catalyst particles and Gd3+ ions. Any such 
coupling might have a profound impact on the transverse relaxation mechanism of GNTs. 
However, until a complete magnetic characterization of empty US-tubes and individual 
contribution from each of the metal catalyst particles are completely understood, the 
present method provides the best available analysis. 
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Part B: Cellular Uptake and Single-Cell Imaging using Gadonanotubes 
The inherent optical properties of SWNTs have been utilized to track them by 
various imaging modalities. For example, in vitro imaging of SWNTs in cells and ex vivo 
imaging in animal tissue have been demonstrated using near-infrared (NIR) fluorescence 
imaging,38,48 Raman spectroscopy,49 and x-ray fluorescence microscopy. 50 In addition, 
several agents such as iodine,!6 fluorescing molecules,S! iron oxide,52 or radiotracers53 
have been attached either to SWNT surfaces or encapsulated within their hollow interiors 
for imaging. By and large, optical microscopy remains the most popular imaging 
modality for visualization of SWNTs in cells and tissue. In general, however, optical 
imaging suffers from low tissue penetration. In most cases, evaluation of SWNT delivery 
by optical imaging can only be confirmed by in vitro experiments or by examining ex 
vivo tissue samples, and the samples often require proper staining for better 
visualization. 54 
Introduction to Cellular Imaging Using Tz-weighted MRI 
In order to track SWNT-based drug delivery platforms in vivo and follow their 
post-treatment biodistribution and their ultimate biological fate, real-time visualization 
and quantification of the SWNT core itself is desirable. Among various diagnostic 
imaging modalities, MRI offers the advantages of non-ionizing, non-invasive, multi-
planar capabilities that favor the long-term tracking of SWNT materials in vivo. 
Currently, molecular and cellular imaging using MRI mostly revolves around the use of 
iron oxide-based r2 agents, such as superparamagnetic iron oxide nanoparticles (SPIOs) 
or micron-sized iron oxide particles (MPIOs).29, 30, 44 In the preceding part of this 
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Chapter, we have shown that GNTs are high-performance rl and r2 MRI CAs. They are 
also a more efficient T2-relaxation agent than SPIOs already in clinical use (Table VII). 
In fact, subcutaneous injection of GNTs dispersed in a biocompatible surfactant 
(Pluronic® F-127) has recently shown excellent negative contrast (T2-shortening) in vivo 
for the first time. 55 
In this part of the Chapter, the intracellular uptake of the GNTs and a method (R2 
& R2* mapping in vitro) to quantify the intracellular uptake for GNTs will be discussed. 
Quantifying the changes in R2 and R2* of the cells by known amount of GNTs 
(quantitative R2 and R2* mappings) allows a method to estimate the cellular uptake of 
GNTs in a non-invasive fashion. The resourcefulness of our method was tested in vivo 
with subcutaneously injected GNT -labeled cells in a mouse. The ability of GNTs to act as 
a high-performance T 2-weigthed MRI CAs as the first non-iron oxide-based T 2 weighted 
CA with the potential to image single cell in vitro is considered below in this part of the 
Chapter. 
MATERIALS AND METHODS 
For MRI measurements and intracellular uptake studies, a stable solution of 
individual GNT was required. A stable and biocompatible GNT suspension was prepared 
by dispersing 10 mg of individual GNTs in 10 mL of 1.0% (w/v) Pluronic® F108 
solution using a probe sonicator. The resulting suspension was centrifuged at 3200 rpm 
for 15 minutes to remove any large aggregates. The supernatant was collected and 
dialyzed (50,000 MW cut-off membrane) against running water for 3 days to remove 
excess surfactant. The Gd3+-ion concentration of GNT suspension was determined using 
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inductively-coupled plasma optical emission spectrometry (ICP-OES, Perkin-Elmer 
Optima 3200V), giving a final concentration of 111 ,...,M Gd. 
Cell Culture and GNT Labeling 
A 1774 mouse macrophages cell line (ATCC, Manassas, VA) was cultured at 37 
°C and 5% CO2 in 100 x 20 mm tissue culture dishes using standard cell culture media, 
containing Dulbecco's Modified Eagle Medium (DMEM, Invitrogen) with 10% fetal 
bovine serum (FBS, Invitrogen) and 1 % Penicillin-Streptomycin (SIP, Fisher Scientific). 
In vitro cytotoxicity of GNTs was first tested in a 96-well micro-plate using a MTS-based 
cell proliferation assay (CellTiter 96® Aqueous One Solution Assay, Promega). To 
optimize the concentration of GNTs that can be used for efficient cell labeling, four 
different concentrations (37.0, 27.75, 15.86, and 12.33 ,...,M Gd) were tested, using 
unlabeled cells as a control. Each concentration was tested in triplicate. 
For cell labeling experiments, 5x105 cells/well were plated in 6-well plates for 24 
hours to allow cell adhesion. The cells were then incubated with GNT suspension diluted 
with the standard culture media (final [Gd3+] = 27.75 ,...,M) for 24 hours. The labeled cells 
were then washed twice with phosphate-buffered saline (PBS, Invitrogen) to remove any 
excess GNTs that might be adsorbed on the cell membrane. 
Fluorescence Staining and Microscopy 
To visualize the sub-cellular localization of GNTs, the labeled cells were stained 
with blue fluorescent Hoechst dye (Invitrogen). Hoechst dye is a cell-permeable nucleic 
acid stain that increases fluorescence intensity when bound to DNA and is commonly 
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used to locate nuclei in cells. The labeled cells were incubated with the dye in culture 
media for about 15 minutes and then examined with fluorescence microscopy (Olympus 
IX51). Bright-field microscopic images were also captured for the same cell samples, to 
observe the localization of GNTs within the cell, as well as to identify the location of the 
cell nuclei. 
In vitro MRI Phantom Preparation 
For in vitro MRI experiments, a portion of the labeled cells was re-suspended in 
an equal volume of 2x DMEM culture media and 2 % agarose gel (Type VII, Sigma) at 
37°C and transferred to 1 cc syringes for MRI phantom studies. The process was 
performed carefully to avoid air bubbles inside the 1 cc syringes and premature gelling of 
the agarose mixture. Four different concentrations of homogeneously-dispersed labeled 
cell phantoms (2.3 xl06, 1.5x1Q6, 0.75 xl06, and 0.57x1Q6 cells/ml) were prepared for 
relaxivity measurements at 3 T. Four phantoms at the same concentration of unlabeled 
cells were also prepared as controls. In addition, a sparsely-distributed labeled cell 
phantom (5,500 cells/mL) was also prepared for single-cell visualization studies at high 
field MRI (9.4 T). All phantoms were cylindrical in shape and about 3.5 cm long. 
The concentration of Gd3+ ions in each of the phantoms was determined by ICP-
OES. From the concentration of Gd3+ ions and the total number of cells, the average 
uptake of Gd3+ ion by each cell was calculated. The measurements were performed in 
triplicate and the mean and standard deviations of the results were also calculated. 
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Animal Preparation 
For in vivo relaxometry measurements, a portion of the GNT-Iabeled cells were 
suspended in PBS and mixed with 1% agarose gel at 37°C for subcutaneous injection 
into the dorsal flank of a female C57BLl6 mouse (Charles River, Wilmington, MA). A 
total of 4x 105 labeled cells/pellet with a volume of 50 JlL was injected into the left dorsal 
flank of the mouse. The injection was done carefully to create an inflated bulb for easy 
localization by MR!. An equivalent unlabeled cell pellet (4xl05 cells) in 1 % agarose gel 
was also injected into the right side of the dorsal flank as a control. The animal was then 
immediately transferred to a 3 T MRI instrument for imaging. The animal experiment 
was approved by the Institutional Animal Care and Use Committee of The Methodist 
Hospital Research Institute. 
MRI Measurements 
MRI was performed in a whole-body 3 T system (General Electric, Milwaukee, 
WI) using a 35 mm inner diameter custom-built quadrature coil for in vitro and in vivo 
relaxivity measurements and in a 9.4 T system (Bruker Biospec 94/20 USR) for the 
single-cell imaging experiment. 
For in vitro relaxivities studies at 3 T, the 1 cc syringes were positioned at the iso-
center of the magnetic bore, with the cylindrical axis parallel to the main Bo field. RJ 
relaxation of the GNT solution was measured using a 2D spin-echo inversion recovery 
(IR) sequence with the following imaging parameters: TRlTE=5000/15 ms, IR = 60 - 150 
ms with 10 ms increment and 200 - 800 ms with 100 ms increment, FOV = 5.0 em, 
51 
matrix = 128 x 128, NEX = 1, thickness = 1 mm, no. of slice = 4. R2 and R2* relaxations 
of the solution were also measured using 2D spin-echo and gradient echo sequences 
respectively, with TR = 1500 ms, TE = 10-45 ms with 5 ms of increment, FOV = 5.0 cm, 
matrix = 192x192, NEX = 1. Circular ROIs were drawn and the R 1, R2 and R2* 
relaxations of the phantoms were computed using non-linear curve fittings of the mean 
intensity of each ROI in the images using Matlab (Mathworks™, Natick, MA). For the 
GNT-Iabeled and unlabeled cells phantoms, the RI, R2, and R2* relaxations were 
measured and computed with similar imaging parameters but using a different range of 
IRs (50-2500 ms) for RI and TEs (15-125 ms with 15 ms increment) for R2 and R2*. The 
net relaxations, ~R2 and ~R2 *, of the labeled-cell phantoms were calculated by 
subtracting the R2 and R2* values of the unlabeled-cell phantom controls from the 
measured R2 and R2 • values of the labeled-cell phantoms. 
For in vivo relaxometry measurement at 3 T, images were acquired by cutting a 
high-resolution oblique slice covering the injected cell pellets on both sides of the mouse, 
with imaging parameters: TR = 1500 ms, TE = 10-45 ms with 5 ms of increment, FOV = 
6.0 cm, matrix = 256x256, NEX = 1. The images obtained were then realigned using 
SPM2 to reduce motion artifacts and fitted mono-exponentially for R2 * mapping using 
Matlab. ROIs were drawn at the two pellets for the R2* maps and overlaid onto an 
anatomical image. The coefficient of determination (R2) map was also computed. 
For single-cell visualization, the sparsely-distributed labeled-cell phantom (5,500 
cells/mL) was imaged at 9.4 T using a 3D spoiled gradient echo sequence (TRITE = 
3000/40 ms, alpha = 28.6°, FOV = 0.64x2.56 cm, resolution = 50 ~m isotropic, NEX = 
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12). The cylindrical axis of the phantom was placed parallel to the main Bo field. 
Reconstruction was done using the susceptibility-weighted imaging (SWI) method, by 
mUltiplying the phase mask with the original magnitude image to enhance the contrast 
effect for better visualization. 56 
RESULTS AND DISCUSSION 
The relaxivity of the GNT suspension was characterized prior to cell labeling in a 
3 T scanner. The relaxation rates (RI' R2 & R2*) of GNT in a 3 T magnetic field is given 
in Table IX. GNT suspension showed an RI relaxation of7.50 S·I, which was equivalent 
to a relaxivity (rl) of 67.57 mM·ls·1 (per Gd3+ ion). R2 and R2* relaxation rates were 47.04 
S·I and 49.88 s·l, respectively. All the fitted curves had R2 values close to 1, indicating an 
excellent fit of the measured data. 
Table IX. Relaxation rates of the GNT solution at 3 T. The coefficient of determination (R2) 
of each measurement is also shown. 
Relaxation rate (S·l) 
Sample 
RI (R2) R2 (R2) R2* (R') 
Gadonanotube 7.50 (0.98) 47.04 (0.99) 49.88 (0.99) 
Cell Viability Studies for GNTs 
F or any cell labeling and imaging studies, it is necessary to optimize the labeling 
concentration of the agent to avoid any adverse effects to the cell. To determine the 
optimum concentration of GNTs that can be used for labeling cells without apparent 
cytotoxicity, we tested four different concentrations of GNTs (37.0, 27.75, 15.86, and 
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12.33 JlM Gd) in a murine macrophage cell line (J774). The cell viability was tested 
using the MTS (3-( 4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium bromide) assay. The MTS assay is a widely-used 
colorimetric method to assess cell proliferation and cytotoxicity of biomaterials. In viable 
(living) cells, the reductase enzymes reduce the MTS dye to Formazan dye giving a 
purple color. Figure 23 represents the cell viabilities of the four different concentrations 
of GNTs tested. When the GNT concentrations are =::; 28 flM Gd3+ the cells exhibited no 
observable toxicity. However, when the labeling concentration was increased to 37 flM 
Gd3+, significant cell death occurred (~ 20 % of the cells). Hence, for the rest of the 
labeling studies we used 28 flM Gd as the labeling concentration. 
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Figure 23. Cell viability studies using an MTS assay. For each concentration, the 
measurements were performed in triplicate and the mean ± standard 
deviation is shown. 
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Cell viability studies showed that at 28 ~M Gd3+, GNTs are non-cytotoxic to 
macrophage cells. However, they do not reveal whether the labeling agent (GNTs) was 
taken up by the cells or just at the periphery of the cell membrane. To visualize the 
uptake and localization of GNTs by macrophages, we used bright-field and fluorescent 
microscopy. Figure 24a is the bright-field image of GNT-Iabeled cell (at 28 ~M Gd3l 
and Figure 24b is the corresponding blue-fluorescent image using Hoechst dye at the 
same cell spot. 
Figure 24. Microscopy images of GNT -labeled macrophage cells (a) Bright-field image of 
cells labeled with 28 flM Gd3+ (b) Blue fluorescence image of the labeled cells, 
captured at identical cell positions as in the bright-field image. 
Figure 24 confirmed the presence of GNTs in the intracellular space. The GNT-
labeled cells appeared black in the intracellular space under bright-field microscopy 
(Figure 24a). To determine whether the GNTs were able to penetrate the nucleus of the 
cells, we used nucleus-staining Hoechst dye. The blue fluorescent microscopy image 
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(Figure 24b) revealed the GNTs are unable to penetrate the cell nuclei under the 
conditions used. From the microscopy images it is clear that the GNTs accumulated 
mostly in the cytoplasm, without penetrating into the nucleus. The Hoechst dye also 
serves as a secondary live/dead assay, since only the nuclei of living cells can be stained. 
The MTS assay and the microscopy results conftrm that the GNTs (28 J.lM Gd3l can 
efficiently label cytoplasm without any adverse effects in macrophage cells. We also 
analyzed the concentration of GNTs inside the labeled cells using ICP-OES. The ICP 
results indicated an average cellular uptake of 0.44±O.09 pg Gd3+/cell, corresponding to 
an uptake of 19.3±3.8 pg GNTs/cell (2.9 % Gd (w/w)). 
In vitro MR imaging 
To generate a method to quantify and track the GNTs (or potentially SWNTs) in 
real-time, we measured the change in relaxation rates (~l' ~R2' ~2·) of cells upon 
labeling them with GNTs. Unlabeled cells were used as controls. The measurements were 
done in a 3 T clinical scanner with increasing number of GNT-Iabeled cells. To avoid 
volume induced artifacts, we homogenously dispersed the labeled cells in 1 % agarose 
gel. Interestingly, we did not observe any change in the Rl relaxation rate of cells upon 
labeling with GNTs. However, the cells showed a higher R2 and R2* relaxation rates 
upon labeling with GNTs. Figure 25 shows the linear relationship of ~2 and ~2· with 
increasing number of GNT -labeled cells. The Gd3+ concentration in each of the cell 
phantoms was measured using ICP-OES (Figure 25b). Figure 25a and 25b conftrm that 
the observed change in the relaxation rate is due to the increasing concentration of GNTs 
in each of the cell phantom. ~2 and ~2· in Figure 25 represents the net change in 
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relaxation rates of labeled cells with the contributions from unlabeled control cells, 1 % 
agarose gel as well as field inhomogenities subtracted. For all the labeled cell 
concentration, the change in R2* (~2*) is much higher than the change in R2 (~2)' 
suggesting that R/ is the dominant relaxation mechanism in GNT-Iabeled cells and R2* 
mapping can be used to quantify the cell population in vivo. 
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Figure 25. (a) ilR2 and ilR2* relaxation measurements of the GNT-labeled cell phantoms 
with increasing number of labeled cells in 1.0 % agarose gel at 3 T. (b) The 
concentration of Gd3+ ions in the phantoms, as determined by ICP-OES. 
It is interesting to note that all of the GNT-Iabeled macrophage cells, regardless of 
the [Gd3l, showed no Rl enhancement upon labeling. However, the stock solution of 
GNTs used for labeling showed considerable Rl relaxation (Table IX). We have also 
seen that when breast cancer cell line (MCF -7) was labeled with serine-derivatized 
GNTs, significant RI relaxation was observed. 57 The observed difference in Rl-
enhancement between different GNT-Iabeled cell lines may be due to difference in the 
intracellular localization of GNTs in different cell line. It is not uncommon for the sub-
cellular localization to affect the longitudinal relaxation of the CAs. It has been reported 
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that the R\ relaxation is sensitive to the CA (Gd-complexes) internalization pathway. The 
entrapment of the CA in the intracellular vesicles through simple pinocytosis could result 
in a three-site water exchange compartmentalization, and the entrapment could slow 
down the water relaxation (decrease the relaxivity) when the CA concentration 
increases. 58 
The GNTs showed considerable difference in R2 and R2 * relaxation rates upon 
internalization in macrophage cell line. It is worth noting that R2 * is only slightly greater 
(- 6 %) than R2 in the GNT stock solution (Table IX), however, the effect is more 
pronounced upon intracellular localization (3-4 times). The close packing of GNTs, once 
localized intracellularly, can induce susceptibility effects resulting in greater R2 and R2· 
relaxation in labeled cells. A susceptibility-induced increase in transverse relaxation rates 
has been previously reported for cells labeled with superparamagnetic iron oxide 
particles.33-35 Transverse relaxation rates are determined more by the magnetic properties 
of the CAs than the chemical nature of the agents. Hence, the superparamagnetic nature 
of GNTs suggests that their transverse relaxation mechanism upon cellular internalization 
could be similar to that of iron oxide nanoparticles. 
In vivo Imaging and Quantification of Labeled-cell Population 
To test the feasibility of using ~R2· mapping for quantification of the labeled-cell 
population in vivo, we subcutaneously injected a known number of GNT -labeled cells 
(8 x l06 cells/mL in pellet form) into the left dorsal flank of the mice and imaged them in a 
clinical 3 T scanner. The labeled-cell pellets were substantially darker than the 
surrounding tissue, whereas, the unlabeled control cells showed negligible contrast 
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difference compared to the surrounding tissue (Figure 26a). This clearly demonstrates 
that the GNTs can be used for in vivo Trweighted MR imaging. The T2* of the labeled 
cells were estimated to be 16.83 ± 5.30 ms corresponding to an R2* value of 65.50 ± 
21.80 s-l. The unlabeled control cells have T/= 40.58 ± 16.26 ms corresponding to an 
R2 * value of 28.60 ± 11.6 S-I. The labeled cells have R2 * enhancement ~2.5 times greater 
than that of unlabeled control cells. The difference in the R2 * relaxation rates (~R2 *) 
between labeled and unlabeled cells is 36.90 S-I. When this value was plotted in Figure 
25a (by extrapolating the linear regression line), it fits well with the data generated using 
other labeled cell concentration (Figure 25a) and the estimated cell population (8.3 xl 06 
cells) is very close to the actual cell population used for the studies (8 x 106 cells). The in 
vivo results demonstrate that ~R2 * mapping can be successfully used to quantify the cell 
population in vivo. The non-invasive nature of MR imaging makes such mapping very 
useful for drug delivery and tracking applications. 
Labeled Cell 
T2* Image R2* Mapping 
Figure 26. In vivo relaxometry measurements of subcutaneously-injected cell pellets in a 
mouse at 3 T. (a) T2* map (in ms) of the injected cell pellets (b) R2* mapping 
(in S-I) with two ROls drawn for the cell pellets and overlaid onto an anatomical 
T2*-weighted image. 
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Single-Cell Imaging 
The ability to track a single cell or small population of cells will have a profound 
impact on our understanding of the disease and the diagnosis and treatment for them. For 
advanced biological applications such as stem cell therapy, tracking cancer cell 
metastasis requires the capacity to image a small population of cells.3o Many different 
imaging modalities such as positron emission tomography (PET), optical imaging, and 
MRI are being actively investigated to achieve single-cell imaging. 59 MRI has 
fundamental advantages over other imaging modalities with deep tissue penetration, non-
invasive nature, and good soft-tissue contrast. For cell tracking using MR imaging, the 
cells are usually labeled with CAs. The inherent low relaxivity (- 4 mM-Is-I) of TI-
weighted paramagnetic CAs such as Gd-chelates and further loss of relaxivity upon cell 
internalization made them unsuitable for single cell imaging applications. However, T 2-
weighted CAs (SPIOs) have recently been shown to provide sufficient contrast to track a 
single cell or small population of cells «500 cells) both in vitro and in vivo. Single-cell 
imaging in MRI has been demonstrated using MPIOs and SPIOS.60,6I However, heavy 
labeling with CA was required to achieve single-cell visualization.3o The strong R2* 
effect of GNTs upon cell internalization allows single cells to be visualized in vitro. 
Figure 27 shows the T2* -weighted image of the sparsely-distributed in vitro cell 
phantom (5,500 cells/mL) at 9.4 T. Figure 27a shows the normal magnitude image of 
cells. Figure 27b shows the reconstruction using the susceptibility-weighted imaging 
(SWI) method, which reconstructs the image using the susceptibility differences in the 
sample. Dark spots were clearly seen in both of the images, but with the spots appearing 
much clearer in SWI reconstructed image. For GNT-Iabeled cells, the dark spots 
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originated from the presence of superparamagnetic GNTs. The GNTs induce a magnetic 
susceptibility effect in their local regions, generating field inhomogenity and thus extra 
dephasing around those regions. The susceptibility difference was utilized for the SWI 
reconstruction method. This is the first time single-cell visualization in MRI has been 
achieved using a non-iron oxide-based CA at 9.4 T (Figure 27a and 27b). SWI is a pure 
post-processing technique that requires no extra imaging time. 
a b 
Figure 27. T2*-weighted image of sparsely-distributed GNT-Iabeled J774 cells suspended in 
1.0 % agarose gel at 9.4 T (a) Magnitude image and (b) susceptibility-weighted 
image (SWI). 
The average intracellular uptake of GNTs in macrophages was determined to be 
0.44±0.09 pg Gd3+/cell using ICP-OES, corresponding to 1.69x 109 Gd3+ ions/cell. This 
result is consistent with our previous study using serine-derivatized GNTs to label a 
MCF -7 human breast cancer cell line57 and is two orders of magnitude greater (l09 vs. 
107 Gd3+ ions/cell) than when water-soluble gadofullerenes were used to label 
mesenchymal stem cells.62 SPIOs have been shown to label macrophages at high loading 
levels via phagocytosis. However, for the high level of intracellular labeling needed to 
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achieve single-cell imaging, SPIO-based CAs require transfection agents. Our results 
show that macrophages can be labeled with lipophilic GNTs very efficiently (~20 
pg/cell), without a transfection agent or advanced labeling techniques. The lipophilic 
nature of GNTs greatly facilitates their use for enhanced intracellular loading in different 
cell lines and allow for single-cell imaging. 
CONCLUSION 
GNTs exhibit exceptionally large and linear transverse relaxivities. When localized 
within the cell, the transverse relaxivities provide GNT with sufficient sensitivity for 
cellular imaging using MR!. The linear change in transverse relaxivities of GNTs can be 
used to track and quantify them in vivo. The large relaxivities also provide the ability to 
track a single cell or a small population of cells using GNTs as a labeling agent. The 
inherent lipophilic nature of the carbon nanotube materials makes them an attractive 
candidate to label cells efficiently without the aid of a transfection agent or advanced 
labeling techniques. However, to realize the complete potential of GNT materials for 
cellular and molecular imaging, studies focusing on the minimum threshold of the 
amount of GNTs per cell to detect them in vivo and the effect of aggregation on the 
transverse relaxivities of the GNTs need to be performed. 
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CHAPTER 5 
Single-walled Carbon Nanotubes as T2-weighted MRI CAs 
Introduction 
Nanomaterials with porous structures are attractive candidates for drug delivery 
applications. Drugs and molecules of biological interest can be confined within the pores 
in a chemically-inert atmosphere (nanoconstruct). The external surface of the 
nanoconstruct can be then chemically functionalized with targeting moieties to enable 
localized delivery of drugs. If carefully designed, such constructs can prevent premature 
release of drugs and undesired accumulation at non-targeted sites, which are the major 
drawbacks of current systemic delivery methods. Considering the advantages offered by 
such agents, a variety of nanomaterials such as gold nanoparticles,63 silicon particles,64 
and SWNTs65 have been studied for their potential for drug delivery applications. 
Diagnostic imaging modalities can be used to track these agents in vivo. The 
imaging is achieved either by loading (or attaching) diagnostic agents in (or to) the 
nanoconstruct or by the inherent properties (magnetic, electronic or optical) of the 
nanoconstruct. For example, gold nanoparticles have near-infrared (NIR) absorbance,66 
silicon particles have been proposed as optical imaging agents,67 and SWNTs have been 
shown to have vibrational signatures (Raman microscopy) and NIR fluorescence.48, 49 In 
spite of having less tissue background fluorescence, NIR imaging still suffers from low 
tissue penetration. NIR imaging of SWNTs is dependent on the SWNT structure, and 
many of the functionalization techniques for SWNTs results in the disruption of the 
SWNT electronic structure, resulting in loss of NIR fluorescence. In the preceding 
63 
Chapter, the exceptionally high transverse relaxivities of GNTs and their ability to act as 
high-performance T 2-weighted MRI CAs was demonstrated both in vitro and in vivo. The 
high transverse relaxivities of GNTs enabled the first non-iron oxide-based single-cell 
imaging. The relaxation measurement studies revealed that US-tubes (with no Gd3+ ion) 
are excellent T 2-weighted MRI CAs. In fact, the majority of the transverse relaxation 
properties of the GNTs are expected to be from the US-tube component. It was 
hypothesized that the transverse relaxation properties (T 2-shortening) can be attributed to 
the presence of metal catalyst particles in US-tubes. In this Chapter, we characterized the 
magnetic properties of SWNT materials to understand the role of carbon SWNTs 
themselves on the transverse relaxation properties. In the previous Chapter, all of the 
studies were performed with SWNTs produced by arc-discharge process, which uses a 
binary metal catalyst (Ni, Y) in the synthesis. To circumvent the complications involved 
in understanding the magnetic properties of binary metal systems, SWNTs produced by 
high-pressure carbon monoxide method (HiPco) were used in this study. The HiPco-
produced SWNTs have only a single metal catalyst (Fe) and still show T2-shortening 
properties. In addition, HiPco SWNTs have a smaller diameter (-1.2 nm) compared to 
arc-produced SWNTs (1.4 nm), making HiPco SWNTs more reactive toward covalent 
functionalization than arc-produced SWNTs. Hence, for biological applications of 
SWNTs involving targeting using covalently-attached targeting moieties to the SWNT 
surface, HiPco SWNTs are preferred over arc-produced tubes. 
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MATERIALS AND METHODS 
Synthesis of SWNT Materials 
The raw SWNTs (r-SWNTs) produced by the HiPco process (Carbon 
Nanotechnologies, Inc) were used for this study. The HiPco SWNTs were grown with 
iron nanoparticles as catalyst. As obtained, r-SWNTs were then purified using a liquid 
bromine (Br2) protocol developed in our laboratory.68 This process not only removes 
the metal catalyst particle significantly (~ 6% remaining), but importantly does not 
disrupt the SWNT structure like many other acid purification processes. Most of the 
metal catlayst particles from outside the nanotube wall in r-SWNTs have been 
removed, and the remaining metal catalyst particles are mainly on the inside of the 
nanotube in purified SWNTs (p-SWNTs). Seperately, the r-SWNTs were cut into 
ultra-short SWNTs (US-tubes) by fluorination and pyrolysis in an inert atmosphere.3l 
The cutting process produces nanocapsules with lengths predominantly between 20-
80 nm. The fluorination also reduces the metal catalyst content further to a negligible 
level (0.6 % by weight) such that no catalyst particles are visible on the outside wall 
of US-tubes. However, it should be noted that the cutting process also produces 
significant damage to the nanotube sidewalls. 
The iron content of each SWNT sample was determined usmg inductively-
coupled plasma optical emission spectrometry (lCP-OES, Perkin-Elmer Optima 3200V). 
The measurements were run in triplicate and the average values were taken for 
concentration calculation. Magnetic properties of the samples were characterized with a 
Quantum Design MPMS-XL magnetometer based on a superconducting quantum 
interference device (SQUID) in the temperature range 5 - 300 K with an applied 
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magnetic field of 0.1 T. Samples were encapsulated in diamagnetic cellulose for 
measurements and run in duplicate. X-ray powder diffraction (XRD) data were obtained 
using a RigakuDlMax-2100PC diffractometer operating with unfiltered Copper Ka 
radiation (/...= 1.5406 A) at 40 kV and 40 rnA. The contribution from the Ka2 radiation 
was compensated for using the Rachinger algorithm. Goniometer alignment was verified 
by daily analysis of a Rigaku-supplied Si02 reference standard. Processing ofthe powder 
diffraction results and phase identification was accomplished using the program JADE. 
In Vitro Relaxometry Measurements 
The T 2-relaxation measurements were performed on a Bruker Minispec mq-60 
(1.41 T) bench top relaxometer (Bruker Optics Inc, Billerica, MA) using Carr-Purcell-
Meiboom-Gill (CPMG) sequence and phantom experiments were performed in a 3 T 
MRI system (General electric, Milwaukee, WI). The phantom images were obtained 
using 2D spin-echo imaging with a repetition time (TR) of 500 ms and echo times (TEs) 
ranging from 10 to 50 ms in either 5 or 10 ms increments. 
The three SWNT materials (r-SWNTs, p-SWNTs, and US-tubes) studied were 
dispersed in equal volumes of bio-compatible Pluronic® (polyethylene oxide-
polypropylene oxide block co-polymer) surfactant using probe sonication for the MRI 
studies. The sonicated solutions were allowed to settle overnight and centrifuged (3200 
rpm for 15 minutes) to produce mostly individual tubes or very small bundles in solution. 
The supernatant was collected and dialyzed (50,000 MW cutoff membrane) to remove 
any excess surfactant. 
The T2-relaxation time (ms) per mg of the SWNT sample (Table XIII) was 
calculated using the linear relationship between the concentration and relaxation time (i.e. 
as the concentration increases the relaxation time (T2) decreases). Based on the iron 
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content, the respective amount of SWNT material present was calculated for the given 
volume used for the relaxation time measurement. Finally, the T 2-relaxation time was 
normalized for one mg of the SWNT material. 
RESULTS AND DISCUSSION 
The effect of SWNT materials on T 2 relaxation times have been previously 
reported, however, such observation has been reported for only r-SWNTs (> 1 f.lm in 
length) and the T2 relaxation properties of the SWNT materials was attributed to the 
metal catalyst impurities (Fe for HiPco-produced SWNTs) present. 52, 69 Metal 
mediated toxicity is a major concern for carbon nanotube based biomedical 
applications.70 The metal catalyst particles cover the tube ends of r-SWNTs,52 which 
might prevent loading of biologically interesting molecules into the interior of the 
SWNTs. In addition, the exact length of SWNTs suitable for biological applications is 
not known, however, SWNTs with length < 300 nm has been shown to be renally 
excreted, and renal excretion is an important consideration for any nanoparticle-based 
biological applications.71 
In order to better understand the role of the metal catalyst particles and the 
length of SWNTs on MRI relaxation properties, r-SWNTs, p-SWNTs, and US-tubes 
were compared. We chose to purify the tubes using liquid Br2 method than 
commonly-known acid purification processes to preserve the electronic and physical 
structure of r-SWNTs. US-tubes, in addition to being shorter in length, also provide 
more available surface-to-volume ratio (Table X), which might be advantageous for 
drug delivery applications. In our laboratory, we have previously loaded the US-tubes 
with magnetic materials for MR imaging, 18 molecular iodine for X-ray CT imaging, 16 
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and a-emitting agents ellAt) for radiotherapy of cancer. 17 
Table X. Surface area measurements of SWNT materials 
p-SWNTs US-tubes 
Transverse Relaxivities of SWNT Materials 
The spin-lattice relaxation time (T 2) of all the three SWNT materials is 
presented in Table XI. The T 2 values are dependent on the concentration of the 
materials. Hence, in order to compare the effect of the SWNT materials, it is 
necessary to compare their relaxivity which is normalized for concentration. 
Calculating the concentration of nanotubes (mM) in solution is very difficult 
considering the vast differences in length and the presence of metal catalyst particles. 
An alternate way of identifying the actual role of nanotubes on the MRI relaxation 
properties is to identify the relaxation properties of the metal catalyst particles and 
assign the rest of the effect to the nanotubes. The presence of single metal catalyst 
particles in HiPco tubes is helpful for such characterizations. In addition, the iron 
particles have been extensively studied for their MRI relaxation properties and are 
well-documented. 4 7 
The relaxivity of the three types of SWNTs to act as T2-weighted MRI CAs 
based on their metal catalyst (Fe) concentration is presented in Table Xl. All three 
SWNTs showed remarkably short T2 relaxation times. But by comparing the 
relaxivities (r2) of the samples, which are normalized for the metal catalyst 
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concentration, it has been determined that a higher concentration of metal catalyst 
nanoparticles does not necessarily mean better T 2-relaxation properties, since, p-
SWNTs are about as effective a T 2-shortening agent as r-SWNTs in spite of having 
three times less iron. Despite having ~28 times less iron, the US-tubes are only 
marginally inferior (~ 2 times) to r-SWNTs in shortening T 2. Comparison of the 
relaxivity, which is normalized for concentration, shows that p-SWNTs and US-tubes 
are much superior to r-SWNTs. This observation is contrary to the reported role of 
metal catalyst particles on the relaxation properties of SWNTs.52, 69 Furthermore, the 
US-tubes, which have the smallest iron content by far, possess the highest relaxivity. 
Table XI. Relaxation times of aqueous SWNT suspension. Measurements were performed 
at 60 MHz & 37°C. For comparison, a clinically-used SPIO T ragent 
(Ferumoxtran®) is also included. [Ref 30] *Based on iron concentration. 
Sample 
To be effective as CAs for advanced applications such as molecular and cellular 
imaging, T2-shortening CAs are expected to have a more pronounced effect on the spin-
spin (T2) relaxation time than on the spin-lattice (T1) relaxation time (greater r2/rl ratio). 
For example, Ferumoxtran®, widely and successfully used as a T2-weighted MRI CA, 
exhibits an r2/rl ratio of ~ 6 (Table 10). Both p-SWNTs (r2/rl >5) and US-tubes (r2/rl >20) 
are very effective as T 2-weighted CAs, but the US-tubes are superior to the clinically-
used agent and possibly more suitable for specialized applications such as imaging 
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biological processes at the molecular level. In fact, their superior r2 efficiency and 
exceptionally large r2/rj ratio, along with their shorter length « 100 nm), makes the US-
tubes unique candidates for such applications. 
The relaxivity measurements mentioned above are the accepted standard by which 
CAs are compared. However, to test their efficiency in a clinical setting, the SWNT-
based CAs were tested for their efficacy in a 3 T clinical scanner. The three SWNT 
materials exhibit different degrees of dispersion in Pluronic® surfactant. Homogenous 
sample concentration is preferred for the phantom experiments, so, dilutions were made 
to produce an equal amount of the SWNTs in all three samples. In order to make 
homogenous solutions, known quantities of each of the three materials in the absence of 
surfactant were analyzed for their iron content by ICP-OES. The ICP measurements were 
run in triplicates (agreement within 2%) to determine the average iron content in each 
sample, as shown in Table XI. Then the SWNT samples dispersed in Pluronic® 
surfactant were analyzed for their iron content, and, from these values, the amount of 
SWNTs present in each of the sample was determined. The samples were then diluted 
such that the concentration of SWNTs in each sample was the same (360 ± 4 mg of 
SWNTs/L) as shown in Table XII. The phantom image of the samples (Figure 28) 
represents the loss of signal as a function of different echo times (TE). The faster the loss 
of signal, the shorter is the T 2-relaxation time. As can be seen in the image, both r-
SWNTs and p-SWNTs have much shorter T2-relaxation times than US-tubes. The actual 
values of the T2-relaxation time of all the three SWNT samples are presented in Table 
XII. Their relaxivity, normalized for their metal catalyst concentration, is also presented 
in Table XII. As observed with the bench-top rei axometer, both p-SWNTs and US-tubes 
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are much superior relaxation agents to r-S WNTs. The observed differences in the 
relaxivity between the 1.5 T bench-top scanner (Table XI) and the 3 T (Table XII) 
clinical scanner is likely due to the dependence of T 2 on magnetic field strength and the 
better optimized imaging parameters in the clinical scanner. 
US-tubes 
r-SWNTs 
p-SWNTs 
TE 
Figure 28. T 2-weighted MRI phantom images of the aqueous SWNT solutions in a 3 T 
scanner. 
Table XII. Transverse relaxivities (r2) of aqueous SWNT suspension. Data collected in a 3 T 
scanner at 37 °e. All samples are at a concentration of 360 ± 4 mg SWNTslL. * 
Based on iron concentration. 
Fe 
Fe % T2 r2 relaxivity 
Sample concentration (mM-1s-1)" (%wt) (ms) 
(mM) 
r-SWNTs 17.2 ± 0.2 1.11 13.6 65 
p-SWNTs 6.1 ± 0.2 0.40 15.1 166 
US-tubes 0.63 ± 0.15 0.04 94.1 230 
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X-Ray Diffraction Studies of SWNT Materials 
The superior contrast enhancement properties of the SWNT materials and the 
observed difference in the relaxation efficiency among the three SWNTs samples studied 
cannot be assigned to the SWNT structure, unless the nature of metal catalyst particles is 
compared between SWNT samples. The comparison of the chemical nature of the metal 
catalyst particles present in each of the SWNT materials is necessitated by the chemical 
processes involved in the preparation of p-SWNTs and US-tubes such as purification by 
Br2 and acid washing using concentrated Hel. X-ray diffraction (XRD) studies were 
performed on all three SWNT samples. The US-tubes did not show any observable XRD 
peaks, which undoubtedly is due to their low iron content « 1 %). XRD data for the r-
SWNT and p-SWNT samples are given in Figure 29. As shown in the figure, both 
samples display similar XRD patterns. The peaks shown were assigned using JADE 
software, and the best fit was observed for Fe304. The XRD results demonstrate that the 
r-SWNT and p-SWNT materials are similar with respect to the iron particles present and 
that these iron particles are predominantly Fe304. 
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Figure 29. Powder X-ray Diffraction pattern of the SWNT materials. 
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Magnetic Characterization of SWNT Materials 
The absence of XRD peaks for US-tubes makes it difficult to understand the 
chemical nature of metal catalyst particles in US-tubes. However, the XRD patterns of p_ 
SWNTs and r-SWNTs suggest that the chemical nature of the metal catalyst particles 
cannot be the reason for the observed difference in relaxivity. The ability of any material 
to act as an MRI CA is determined mainly by their magnetic properties. Fe304 particles 
can act either as a ferromagnetic or superparamagnetic material depending on particle 
size.72, 73 In addition, most of the chemical processes involved in the synthesis of p-
SWNTs and US-tubes from r-SWNTs are standardized procedures aimed at developing 
nanotube materials suitable for biological applications. Hence, magnetic characterization 
of the SWNT materials as such (without modifying the processes) would be more 
informative and reproducible for real time applications. The SWNT materials were 
characterized for their magnetic properties by SQUID magnetometry (Figure 30). The r-
SWNTs (Figure 30a), p-SWNTs (Figure 30b), and US-tubes (Figure 30e) data are all 
consistent with superparamagnetism: the zero-field-cooled (ZFC) curves are 
characterized by a mean blocking temperature, T B, above which the material is 
superparamagnetic and below which magnetic viscosity gives rise to a hysteretic 
magnetization loop. This arc nature of the zero-field-cooled (ZFC) or field-cooled (FC) 
curve is representative of either superparamagnetism or spin-glass state. However, the FC 
curve in all the SWNTs samples are reversible, ruling out the possibility of the presence 
of spin-glass system.74 Furthermore, the maximum blocking temperature, TB,max, or the 
temperature where initial bifurcation between the ZFC and FC curves occurs, decreases 
with purification from r-SWNTs to US-tubes (Figure 30). This indicates that as TB,max 
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approaches Ts , the net distribution of superparamagnetic domain sizes become more 
uniform. The magnetic characterization of the SWNTmaterials also provides information 
about the average size of the metal catalyst particles assuming the observed magnetic 
properties are that of metal catalyst particles. Using a TB of 40 K and the magnetic 
anisotropy constant K of bulk Fe304, 4 x 105 erg cm-3 (the majority of residual catalyst in 
HiPco SWNTs exists as magnetite),75 we calculate a mean particle volume V= 3.45 x 10-
19 cm3, or a mean particle radius r = 4.35 nm using T B = KV / 25ks ,76 and slightly smaller 
particles for US-tubes. When compared to similarly-sized iron oxide particles (2-4 nm) 
with r2 = 72 mM-1s- t, the p-SWNTs and US-tubes far outperform their solely iron oxide-
based counterpart.77 
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Role of SWNTs on Transverse Relaxivities of SWNT Materials 
Complete characterization of the metal catalyst nanoparticles in US-tubes by 
XRD is not available. However, the magnetic measurements reveal that the US-tubes are 
not significantly different from r-SWNTs and p-SWNTs in their magnetic properties. 
Hence, the superior relaxivity of the SWNT materials, and especially of the US-tubes and 
p-SWNTs, clearly suggests that the role of the carbon SWNTs themselves should not be 
ignored when interpreting the resultant magnetic and T 2-relaxation properties. There are 
few reports on the literature documenting inherent magnetic properties of SWNTs.78, 79 In 
fact, finite zigzag carbon nanotube materials are shown to be inherently paramagnetic. 
The magnetic properties are attributed to their chirality, diameter, and length, with 
shorter-length tubes being potentially more magnetic.78 In case of US-tubes, the 
abundance of defect sites on the SWNT surface could also add to the magnetic properties 
in the nanotube materials as wel1.79 These results all suggest that it is not correct to assign 
the magnetic properties of SWNT materials to metal catalyst nanoparticles alone. In fact, 
superparamagnetic SWNT materials may be a distinct new class of T 2-weighted MRI CA 
with performance contributions from both iron oxide and the carbon SWNT material 
itself. Hence, their T 2-relaxation times are probably better expressed as a function of 
SWNT material concentration (ms.mg-1), as also presented in Table XIII. Calculating the 
exact contribution of SWNT materials has not been achieved due to the non-availability 
of SWNT materials completely devoid of metal catalyst nanoparticles. 
Table XIIL T z-relaxation times of SWNT samples per mg of SWNT materials. 
Sample 
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CONCLUSION 
The synergistic effect of metal catalyst nanoparticles and carbon SWNTs offer a 
new paradigm in T2-weighted MR imaging. The lipophilic nature of SWNTs provides 
them the ability to trans locate the cell membrane without the help of any transfection 
agents. The bioinert nature of the SWNTs and the recent advancements in their 
functionalization chemistry makes them appealing for cell and gene delivery applications. 
Our results suggest that the magnetic properties of SWNTs, even in the presence of 
negligible amount « 1 %) of metal catalyst particles, offer a way to track them in vivo 
using MR!. The superior relaxivity of the p-SWNTs and US-tubes over the r-SWNTs is 
also noteworthy since these materials, when used as in vivo MRI agents, should 
demonstrate better sample purity and reduced metal-mediated toxicity. US-tubes, with 
their shorter length, superior relaxivity, and negligible metal content appear to be the 
most promising SWNT material of all for in vivo magnetic cell labeling/trafficking 
studies and other molecular imaging applications. 
CHAPTER 6 
Optimizing the Contrast Enhancement of Gd-Based CAs by 
Geometrical Confinement 
Need For Optimization 
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The design and synthesis of new clinical MRI CAs has seen enormous progress in 
recent years. Generally, most of the clinically used CAs have relaxivities smaller than 4 
mM-1s-1 (Table XIII). Theoretical models predicts the possibility of much larger 
relaxivities for Gd-chelates (~ 150 mM-1s-1 per Gd3+ ion) with optimized electronic, 
exchange, and motional correlation properties.9 Hence, there is a constant effort to design 
new MRI CA systems with optimized properties. In this work, we demonstrate the use of 
geometrical confinement to enhance the longitudinal relaxivity (rJ) of Gd-based CAs. 
Intravascularly-injectable nanoporous silicon particles (SiMPs) were used as the 
confinement platform and individual GNTs as the Gd-based CA. 
Table XIV. Longitudinal relaxivities of clinically-used Gd-chelates at 1.41 T and 37°C. 
CA rl [mM-1s-1] per Gd3+ ion 
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MATERIALS AND METHODS 
Fabrication. surface modification and characterization of mesoporous Si particles 
(SiMPs) 
Hemispherical porous silicon particles with 1.6 J.1m diameter and discoidal porous 
silicon particles with 1.0 J.1m diameter and 400 nm thickness were used in the study. All 
the particles were fabricated in the Microelectronics Research Center at The University of 
Texas at Austin by combination of standard photolithography and electrochemical 
etching. Hemispherical particles were fabricated following protocols previously 
reported.64 Discoidal particles were fabricated by newly developed protocols: briefly, 
heavily doped p++ type (100) silicon wafers with resistivity of 0.005 ohm-cm (Silicon 
Quest, Inc, Santa Clara, CA) were used as the silicon source. A 400 nm porosity layer 
was formed by applying a 7 mAlcm current for 125" in a 1:3 HF (49 %) ethanol solution. 
The electrical current was then increased to 76 rnA/cm and applied for 8" forming a high 
porosity release layer. A 40 nm Si02layer was deposited by low pressure chemical vapor 
deposition at 400°C. Standard photolithography was used to pattern a 1.0 J.1m circular 
pattern with 1.0 J.1m pitch over the Si02 capped porous layer using a contact aligner 
(K.Suss MA6 mask aligner) and NR9-500P photoresist (Futurrex Franklin, NJ, USA). 
The pattern was transferred into the porous double layer by dry etching in CF4 plasma 
(Plasmatherm 790, 25sccm CF4, 100 mTorr, 200W RF). The capping Si02 layer was 
removed in 49 % HF, and the particles were released from the substrate by sonication in 
isopropanol. The particles were treated with H202 at 100°C to oxidize the surface. 
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Fabrication and surface modification ofGNTs 
Individual GNTs were synthesized using the protocol described in detail In 
Chapter 2, Materials and Methods section. 
Fabrication and surface modification of GFs 
Polyhydroxylated Gadofullerenes [Gd@C6o(OH)x; x -27] (obtained from TDA 
Research Inc.) were dissolved in HPLC grade water. The resulting solution was passed 
through a 0.2 11m filter and centrifuged at 3200 rpm for 10 minutes. The resulting 
supernatant solution was used for loading and MRI characterization. 
Loading of the porous Si particles (SiMPs) with Magnevist® (MAG), Gadofullerenes 
(GFs), and Gadonanotubes (GNTs) 
For loading the pores of the Si particles with the Gd-CAs, known amounts of 
mesoporous silicon particles were lyophilized to dryness for 6 hours in non-stick plastic 
tubes using Labconco® FreeZone™ Freeze Dryer system. Two protocols were tested: (1) 
single-step loading and (2) sequential loading. During the first experimental setup, dry Si 
particles were mixed with 300 ilL of Gd-CAs (Magnevist, GNTs or GFs) solution. The 
resulting suspension was sonicated (30 W bath sonicator) for 5 minutes and centrifuged 
for 10 min at 3200 rpm. The supernatant was discarded and the flocculated particles were 
washed twice with DI water to remove any excess of Gd-CAs adhering to the outer 
surface of the Si particles. For the sequential loading experiments, the Si particles were 
introduced initially into 100 ilL of Gd-CAs stock solutions, followed by sonication and 
centrifugation. After the supernatant was discarded, another 100 ilL of the stock solution 
was added, followed by sonication and centrifugation. The process was repeated with 
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addition of another 100 ilL of stock solution (total volume of the stock solution added is 
300 IlIL), followed by loading and washing twice with DI water. In order to estimate the 
efficiency of loading, the particles were dissolved in 1 N NaOH overnight. The resulting 
solution was treated with -26 % HCI03 and heated to dryness. The resulting precipitate 
was dissolved in 2 % HN03 and Gd3+ ions released from the particles during the 
degradation process were analyzed using ICP-OES. 
Scanning electron microscopy 
Samples were mounted on SEM stubs (Ted Pella, Inc.) either using conductive 
adhesive tape (12 mm OD PELCO Tabs, Ted Pella, Inc.) or by applying wet samples to 
stubs and air drying in a desiccator. Samples were sputter coated with a 10 nm layer of 
gold using a Plasma Sciences CrC-150 Sputtering System (Torr International, Inc.). 
SEM images were acquired under high vacuum, at 20.00-30.00 kV, spot size 3.5-5.0, 
using a FEI Quanta 400 FEG ESEM equipped with an ETD (SE) detector. 
Relaxometry studies 
T I-relaxation times of GNTs in nanoporous silicon particles were measured in a 
Bruker Minispec bench-top relaxometer operating at 60 MHz and 37°C. TI-relaxation 
times were measured using inversion recovery sequence and HPLC grade water was used 
as diamagnetic control. 
Phantom studies in clinical scanner were performed in a 1.5 T commercial 
scanner (Achieva, Philips Medical Systems, Best, The Netherlands) equipped with a 32-
channel radiofrequency system. A 32- or 16-element phased-array surface coil was used 
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for MR signal reception. An inversion recovery sequence was used for image acquisition 
with TR = 7500 ms and TE = 20 ms. 
RESULTS AND DISCUSSION 
The SiMPs were micro fabricated using a combination of photolithography and 
electrochemical etching that allows for controlling the size, shape, and porosity of the 
particles.64,80 The shape can be hemispherical, quasi-hemispherical, or discoidal with an 
effective diameter ranging from 600 nm to a few microns. The diameter of the pores can 
be tailored to be between 10 nm (small pores) and 100 nm (large pores). GNTs were 
loaded within the nanopores of quasi-hemispherical (H-SiMPs) particles, with a nominal 
diameter of 1.6 11m and thickness of about 111m, and discoidal (D-SiMPs) particles, with 
a nominal diameter of 1.0 11m and thickness of about 0.4 11m (Figure 31). The average 
pore size ranges between 30-40 nm for both SiMPs. 
The generality of our procedure was also tested for two other Gd-based CAs, 
namely Magnevist® (MAG), and gadofullerols (GFs). Magnevist (Gd-DTPA) is a 
gadolinium polyaminocarboxylate complex (Figure 31a), widely used in the clinic as a 
T I-weighted MRI CA. 10 GFs are new carbon nanostructure-based lipophilic CAs showing 
enormous promise as MRI CAsY GFs used in this study have a single Gd3+ ion 
encapsulated by a spherical C60 fullerene cage of ~ 0.7 nm in diameter (Figure 31b). The 
external fullerene cage prevents the leaking of the Gd+3 ions, and a functionalization 
platform for solubility and biocompatibility. It is important to note that GFs are known to 
aggregate in solution even after functionalization. 
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Figure 31. Schematic representation of the Gd-based CAs: a) Magnevist®, b) a GF, and c) a 
individual GNT. d) & e) SEM images of hemispherical and discoidal Si particles, 
respectively. t) schematic representation of the confinement of the Gd-CAs in 
nanoporous SiMPs. 
Comparison of Loading Protocols 
The loading and confinement of GNTs within the SiMPs occurs primarily through 
capillary forces. 82 Two different loading procedures were attempted in this study: i) a 
single-step loading and ii) a sequential loading. In the sequential loading process, a 
concentrated solution of GNTs ([Gd31 = ~67 /lM) was exposed to SiMPs in a stepwise 
fashion. The SiMPs were washed with HPLC grade water after each step. The amount of 
Gd3+ ions loaded within the nanoconstructs was determined by ICP-OES. The two 
loading procedures showed no difference in the concentration of Gd3+ ions confined 
within SiMPs (Figure 32). Some GNTs were seen adhering to the outer surface of SiMPs 
in the single step loading procedure (Figure 33 A). In contrast, sequentially-loaded 
82 
SiMPs showed no such external adhesion, suggesting complete entrapment of GNTs in 
the nanopores (Figure 33 B). Hence, the sequential loading process was used for the 
preparation, characterization, and study of the nanoconstructs. A similar sequential 
loading protocol was also used for loading and confinement of MAG and GFs within 
SiMPs. 
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Figure 32. Comparison of the two loading protocols used for the geometrical confinement of 
GNTs in SiMPs. 
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Figure 33. SEM images of a) SiMPs loaded with GNTs using the single-step procedure or b) 
SiMPs loaded with GNTs using the sequential loading procedure. 
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Magnetic Characterization of Gd-CAs/SiMP Nanoconstruct 
A bench-top relaxometer (Bruker Minispec mq-60; 60 MHz) was used for the T 1-
relaxation measurements of our nanoconstructs. Empty SiMPs alone showed no 
observable relaxation properties. Figure 34 represents the longitudinal relaxivities (rl) 
measured for six different nanoconstructs using a bench-top relaxometer. Compared to 
the Gd-CAs (GNTs, GFs, MAG) alone, the nanoconstructs exhibited significantly higher 
rl. To test the ability of the CA in clinical settings, we performed phantom measurements 
on representative H-SiMP/GNT nanoconstruct in a clinical 1.5 T scanner (Figure 35). 
The H-SiMP/GNT construct showed a significantly lower inversion time (Tinv= ~ 1200 
ms) compared to empty SiMP (Tinv= ~1700 ms), demonstrating that the contrast 
enhancement is due to the GNTs within the H-SiMP/GNT nanoconstruct. 
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Figure 35. Phantom measurements in a clinical 1.5 T MRI scanner. 
Rationale behind Improved Relaxivity 
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The longitudinal relaxivity (rI ) of a CA has two components: the inner-sphere 
relaxivity rI IS, and the outer-sphere relaxivity rl os. The outer-sphere mechanism involves 
random translation diffusion of bulk water in the vicinity of paramagnetic center and as a 
result can be hardly modified. Hence, most of the research about the design of new, high-
efficiency CAs focuses on optimizing the inner-sphere parameters to optimize the 
relaxivity. Inner-sphere parameters include the number of inner-sphere water molecules 
(q), the molecular tumbling time of the CA with inner-sphere water molecules (rR), and 
the proton residence time ('tm) of the water molecules in the inner-sphere. 
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This has lead to the development of a number of nanoparticle-based CA 
constructs. Paramagnetic liposomes containing Gd3+-ions (rl=ll mM-1s-1 at 25 MHz),83 a 
dendrimer-based nanoprobe, obtained by covalent attachment of Gd-chelates to PAMAM 
dendrimers (rl=20 mM-1s-1 at 130 MHz),84 Gd3+-complexes bound to human serum 
albumin (rl = 130 mM-1s-1 at 20 MHz),85and chelation of Gd3+ ions with protein 
molecules (rl= 130 mM-1s-1 at 65 MHz)86 have all been shown to be effective at 
improving relaxivity. Most of these studies are based on engineering the bond between 
Gd3+ ions and surrounding molecules, with the aim of increasing the rate of water 
exchange (reduced 'tm) and the characteristic tumbling time ('tR), and thus, require a 
specific interaction. However, our method is a more general approach for enhancing the 
longitudinal relaxivity (rl) of Gd-CAs, namely, that the characteristic parameters q, 'tR, 
'tm, and 'tD can be appropriately modified by confining the CA within a nanoporous 
matrix. 
The role of geometrical confinement on the above-mentioned parameters of the 
nanoconstructs was analyzed to interpret the observed boost in their relaxivity. The 
bench-top relaxometer results and clinical phantom studies confirmed that the SiMPs 
themselves do not have any proton relaxation properties. For Magnevist®, the inner-
sphere and outer-sphere mechanism contribute nearly equally to the longitudinal 
relaxivity. The effect of confining MAG within the pores SiMPs can be several-fold: 
increase the molecular tumbling time 'tR (inner-sphere), reduce the mobility of the outer-
sphere water molecules, thus increasing the diffusion correlation time, 'tD (outer-sphere), 
and alter the proton residence time ('tm) of inner-sphere water molecules inside the pores. 
86 
The GFs/SiMP nanoconstructs exhibited large standard deviations in relaxivity. 
The observed relaxivity variations are most likely due to presence of empty fullerenes 
(nearly 60 %) in the GF stock solution. The inability to separate Gd@C60 fullerenes 
completely from empty C60 fullerenes is, in fact, a concern for metallofullerene-based 
biological applications. The interpretation of the improved relaxivity of GFs/SiMP 
nanoconstruct is even more challenging because of the unique and still not fully 
understood behavior ofGF themselves.46 The presence of hydrophobic C60 fullerene cage 
prevents any direct interaction between Gd3+ ion center and water protons. Such shielding 
suggests no traditional inner-sphere like mechanism is possible for GFs. However, the 
hydroxyl groups (in Gd@C60(OH)x) on the surface of the fullerene cage leads to an inner-
sphere like mechanism. GFs exist as aggregates even after functionalization. Initial 
studies attributed the aggregation leading to a lower tumbling time ('tR) as the reason for 
the improved relaxivity of GFS.87 However, it was recently reported that the water 
molecules trapped in the interstices of these aggregates (larger diffusion correlation times 
'tD) are likely the source for improved relaxivity of GFS.46 The loading of GFs into 
nanopores could favor aggregation and possibly coordinate interactions among adjacent 
clusters of GFs. Confining GFs within the nanoconstruct might also lead to an increase in 
diffusion correlation time ('tD)' However, a thorough interpretation of the enhancement in 
relaxivity due to geometrical confinement of GFs is only possible with nanoconstruct 
loaded with only GFs and not empty fullerenes as well. 
GNTs are much more homogenous than GFs. The parameters likely affecting the 
relaxivity of individual GNTs are already predicted using the SBM theory (Chapter 3; 
Table III). The slow molecular tumbling (greater 'tR) of GNTs suggests that inner-sphere 
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relaxivity is the most dominant mechanism of GNTs.45 The nanoconstruct obtained by 
loading individual GNTs into the SiMPs (quasi-hemispherical and discoidal) 
demonstrated a rl relaxivity of -150 mM-1s-1 at 1.41T, which is significantly larger than 
the -90 mM-1s-1 observed for the individual GNTs before loading. The increase in 
relaxivity observed for the nanoconstruct is likely due to the organization of individual 
GNTs within the pores. Inside the pores, GNTs packed in close proximity to one another 
resemble a uniform GNT aggregate (pseudo-aggregation). The pseudo-aggregation of 
GNTs within the nanopores is further corroborated by the relaxivity of GNT/SiMP 
nanoconstruct (~ 150 mM-1s-1 per Gd3+ ion) which resembles that of bundled GNTs (~ 
170 mM-1s-1). Pseudo-aggregation of GNTs inside SiMPs could result in water molecules 
getting trapped in the interstices of the GNT aggregates. Water molecules trapped 
between GNTs inside SiMPs could enhance the overall relaxivity of the nanoconstruct 
like second sphere water molecules in the case of some more common Gd-complexes.88 
In addition, the confinement of GNTs within the SiMPs could increase their tumbling 
time, 'tR, to an even greater extent because of the contact with the pore walls and an 
increase in effective viscosity of the water molecules trapped within the pores. 
CONCLUSION 
In summary, we show that confinement of MRI CAs in nanopores of SiMPs can 
result in a boost in their longitudinal relaxivity. Our method is quite general and can be 
used for any Gd-based CA. We successfully examined the generality of our principle by 
confining three different Gd-based CAs within SiMPs. Geometrical confinement can 
reduce the ability of CAs to tumble, decrease the mobility of the water molecules, and 
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favor clustering and mutual interactions among the loaded CAs, thus altering the original 
values of the governing parameters q, 'tm,'tR, and 'to, and potentially others, as well. The 
diamagnetic nature of SiMPs suggests that other nanomaterials-based constructs (such as 
Au NPs) can enhance relaxivity equally effectively. The SiMPs also offer a formidable 
particle-based system for efficient intravascular delivery. The size, shape, and surface 
properties of the SiMPs can be rationally designed and tailored for favorable 
pharmacokinetics and biological targeting.89-91 Finally, the porous structure of our 
nanoconstructs can be loaded with multiple agents, such as other nanoparticles and/or 
small molecules and drugs,92 to generate highly-multifunctional systems with both 
imaging and therapeutic capabilities. 
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FUTURE DIRECTIONS 
GNTs as low-field MRI CAs 
The longitudinal relaxivities of GNTs as measured in a 0.2 T scanner are the first such 
measurements of GNTs in a clinical setting. The relaxivity values of GNTs are 
significantly higher than conventional Gd-chelates at all magnetic field strengths. 
However, the unusually high relaxivity of GNTs below 10 MHz (Larmor frequency) is 
unique and difficult to explain using traditional MR relaxation theory. Detailed studies 
such as temperature dependent NMRD and 0-17 NMR studies (to determine the proton 
exchange rate) are required to understand the low-field behavior of GNTs. 
It is also interesting to note that GadoDex exhibits a much higher relaxivity (~ 
800 mM-1s-1 per Gd3+ ion) than Pluronic®-coated GNTs (~350 mM-1s-1). This is contrary 
to the observation at medium-to-high magnetic field strengths (10-100 MHz) where there 
is no significant difference in relaxivity between GadoDex and Pluronic®-coated GNTs 
(~ 70 mM-1s-1at 1.41 T). The symmetry of the CAs and molecular vibrations are known 
to produce interesting properties at low-field strengths. ll One of the observable structural 
differences between pluronic®-coated GNTs and GadoDex is the mechanism of nanotube 
suspension. Many of the polymers (including Pluronic®) are known to wrap around the 
SWNT surface, whereas, carboxylated-dextran suspends the US-tubes only in the 
presence of Gd3+ ions (Figure 36). Hence, further experiments are needed to understand 
the interaction between the Gd3+ ions of the GNTs and carboxylated dextran and the 
impact of these interactions on the symmetry and molecular vibrational properties of 
GNTs. 
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Pluronic wrapped GNTs GadoDex 
Figure 36. Schematic representations ofPluronic-coated GNTs and GadoDex. 
In addition, it has been observed that the intracellular contrast enhancement is 
highly dependent on the concentration of GNTs within the cell. However, it is probably 
not correct to attribute the contrast enhancement solely to concentration-based 
aggregation of GNTs inside the cells. Each cell compartment has unique water exchange 
properties (which affect the proton relaxation mechanism); however, GNTs of our studies 
have not been specifically targeted to any sub-cellular compartment. GNTs 
functionalized to specifically target a cellular compartment would give us an 
understanding of the effect of sub-cellular localization on the proton relaxation 
properties. In addition, the threshold [Gd3+] needed for an observable MR signal at low-
field strengths needs to be established to enable molecular and cellular MR imaging at 
low fields. 
GadoDex 
The biologically benign properties of dextran offer exceptional promise for the use of 
GadoDex as an intravascular MRI CA and also for advanced applications such as cellular 
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and molecular imaging. The ease of functionalization of the dextran moiety should help 
in achieving specific targeting with peptides and/or antibodies. Although, GadoDex 
exhibited a longitudinal relaxivity (rl) ca. 25 times greater than clinically-used Gd3+_ 
complexes, the fitting of the nuclear magnetic relaxation dispersion (NMRD) curve 
indicates that the number of inner-sphere water molecules (q = 2) is not significantly 
different from conventional Gd-chelates (q = 1-2). This is surprising considering the fact 
that US-tubes do not interact chemically with Gd3+ -ion clusters. Hence, most of the 
coordination sites of hydrated Gd3+ ion (q = 8-9) were expected to be available for proton 
exchange with bulk water. Some of these coordination sites may be accounted for by the 
formation of hydroxyl bridges among Gd3+ ions in GNTs, and the shielding by the 
hydrophobic US-tube surface. However, we believe that the dispersion of GadoDex is 
due to a weak carboxylate (from dextran)-Gd3+ interaction (Figure 33). This certainly 
would decrease the number coordination sites available for proton exchange in GadoDex. 
One of the possible ways to optimize the relaxivity of GadoDex without affecting the 
dispersibility is to covalently functionalize the GNT surface with the dextran moiety. In 
addition, it was also observed that GadoDex lacks solution stability in phosphate-buffered 
saline (PBS) (visible precipitation of GNTs occurs in 1 hour). This lack of stability will 
hinder the development of GadoDex for imaging applications that require prolonged 
blood circulation properties. One of the possible reasons for the lack of stability of 
GadoDex is the weak coordination bond between Gd3+ ions and the carboxylate groups. 
Thus, covalent functionalization of GNTs with dextran should also assist in the stability 
of GadoDex under physiological medium. 
GNTs and US-tubes as T rweighted MRI CAs 
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GNTs exhibit very-high transverse relaxivities at high magnetic field strengths (~ 
3T). Their lipophilicity and exceptionally large relaxivities have resulted in the first non-
iron oxide-based CAs for single-cell imaging. It has been observed that the aggregation 
of GNTs within the cell plays a pivotal role in the transverse relaxation properties of 
GNTs. All of our studies were performed with polymer wrapped tubes, which are not 
targeted. It is also known that the Pluronic® coating is quickly replaced by proteins in 
physiological medium. This might be the main reason for the observed aggregation of 
GNTs within the cell. However, for biological applications involving GNTs, covalent 
functionalization is preferred over non-covalent dispersion of GNTs. In such cases, the 
aggregation of GNTs will likely be considerably different. Hence, for clinical translation 
of our in vitro and in vivo results of GNTs as T2-weighted MRI CAs, the role of the 
functionalization (non-covalent vs. covalent) needs to be more thoroughly understood. 
The inherent transverse relaxation properties of SWNT materials offer a possible 
method to track the long-term fate of SWNT-based technologies in biology. Better 
relaxivities with lower metal catalyst content suggest that the role of the SWNT structure 
cannot be neglected. However, the non-availability of metal free SWNTs makes this 
suggestion only a hypothesis. It was observed that, regardless of the synthesis procedure 
and the nature of metal catalyst particles, the SWNTs are excellent T2-weighted MRI 
CAs. However, a comparison between SWNTs produced by different methods could not 
be achieved in this work due to the lack of complete magnetic characterization of the 
SWNT materials other than that of HiPco origin. Hence, studies focusing on magnetic 
characterization of SWNTs should help optimize the T 2-relaxation properties of SWNT 
materials for all biological applications. 
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